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ABSTRACT 
Receptors on the cell membrane initiate cell signaling upon stimulation with 
extracellular molecules; this results in signal transduction pathways. Receptors are 
redistributed as clusters upon extracellular stimuli with the change of receptor dynamics. 
The lateral diffusion of receptors plays a role in how receptors interface with other 
membrane proteins, extracellular ligands, intracellular proteins, and how receptors 
function. In this dissertation, the lateral diffusion and clusters of receptors for advanced 
glycation end-products (RAGE) at both a single molecule and the ensemble level are 
discussed. The effects of extracellular ligands, cholesterol levels, and actin 
polymerization on RAGE diffusion are considered.  
RAGE is a member of the immunoglobulin superfamily of membrane proteins 
that are involved in numerous pathological conditions. Ligand binding to the extracellular 
domain of RAGE drives RAGE clusters and initiates the downstream signal transduction. 
The signal transduction also consists of the interaction between diaphanous-1 (Diaph1) 
with the cytoplasmic tail of RAGE. Diaph1 affects the nanoscale clustering and diffusion 
of RAGE as measured by super-resolution stochastic optical reconstruction microscopy 
(STORM) and single particle tracking (SPT). A reduced expression level of Diaph1 or a 
disrupted interaction between Diaph1 and RAGE results in a decreased size and number 
of RAGE clusters. RAGE diffusion is increased after reduced Diaph1 expression. In 
contrast, when the interaction site between RAGE and Diaph1 is mutated, RAGE 
diffusion is slowed.  
The effect of the ligand on the lateral diffusion of the receptor for advanced 
glycation endproducts involved in numerous pathological conditions. A methylglyoxal-
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modified bovine serum albumin (MGO-BSA) RAGE ligand is prepared and 
characterized. The effect of MGO-BSA on the lateral diffusion of RAGE is measured by 
SPT. Ligand incubation affects RAGE diffusion and the phosphorylation of extracellular 
signal-regulated kinases. However, there is no correlation between MGO-BSA ligand 
binding affinity and the change in RAGE diffusion. Moreover, the mechanism for the 
ligand-induced change in RAGE diffusion is dependent on cholesterol. 
The actin cytoskeleton plays a crucial role in RAGE functions. The effect of the 
actin cytoskeleton on RAGE diffusion is measured by fluorescence recovery after 
photobleaching at the ensemble-level. When depolymerization of the actin cytoskeleton 
is inhibited, RAGE diffusion and mobile fraction are decreased. Also, when the actin 
cytoskeleton is disrupted, the phosphorylation of extracellular signal-regulated kinase is 
reduced.   
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CHAPTER 1.    GENERAL INTRODUCTION 
 1.1 Receptor Proteins Dynamics and Clustering 
Albert Einstein said: “Life is like riding a bicycle. To keep your balance, you must 
keep moving”. With his “keep moving” contribution improving the reality of small particles 
and their motions in 1905, the extensive studies about dynamics have emerged in both 
macroscopic and microscopic environment. A fluid mosaic model was proposed by S. 
Jonathan Singer and Garth Nicolson in 1972 to describe the general structure of a biological 
membrane wherein the protein can diffuse freely [1]. A receptor acts as a doorbell on the cell 
membrane; it provides a route for communication between the outside and inside of the cell. 
This process is called signal transduction. Each receptor is involved in a specific set of signal 
transduction events. This signal transduction set off by one particular receptor-ligand binding 
event, which can initiate one or several signal pathways [2-5]. Defects in signaling pathways 
are implicated in a large number of diseases such as cancer [6], cardiovascular disease [7], 
diabetes [8] and many forms of mental illnesses [9, 10]. For example, epidermal growth 
factor receptor overexpression has been found in cancer cells [11]; Toll-like receptor 
activation contributes to the development and progression of cardiac dysfunction in sepsis 
and congestive heart failure [12]; Alzheimer’s disease and Down’s syndrome are caused by 
aberrant catabolism of a cell-surface receptor [13].   
Receptor dynamics and conformational changes contribute to transferring the signal 
into cells. Although the correlations between signal transduction and receptor dynamics vary 
from one receptor to another, a canonical principle is emerging. Receptors undergo 
oligomerization upon stimulation with extracellular ligands, which include hormones, drugs, 
and other proteins, that result in the activation of the protein-tyrosine kinase. Subsequently, 
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the phosphorylation of tyrosine residues transmits the signal to the intracellular protein, 
which leads to these receptors’ mobilization on the cell membrane [14]. Many receptors 
redistribute into receptor clusters or conformation in conjunction with the change of receptor 
dynamic upon the ligand induction [15, 16]. In addition to extracellular stimuli interactions 
with other receptors may also affect membrane dynamics and clustering. The vital role of the 
actin cytoskeleton in controlling receptor compartmentalization, dynamics, and clustering 
have been reported [17]. Over the past decade, a larger number of analysis techniques have 
been developed to measure receptor dynamics and clustering. The imaging techniques are 
reviewed in Chapter 1.2. 
 
1.2 Traditional Imaging Techniques for Receptor Dynamics and Clustering in Living 
Cells 
In order to describe the entirety of receptor dynamics and organization, it is necessary 
to combine the kinetic state at a multidimensional spatiotemporal scale and the 
conformational state at a multidimensional energy landscape [18]. Researchers have worked 
relentlessly for many years to obtain this information using a variety of biophysical 
techniques, such as x-ray scattering [19], magnetic resonance spectroscopy [20, 21], mass 
spectrometry [22, 23], and vibrational spectroscopy [24, 25]. These analysis methods cover a 
broad range of spatial scale (from sub-angstroms to tens of angstroms) and time scale (from 
sub-picoseconds to seconds). Nowadays, computational techniques are aiding in providing 
the connection between structural information and dynamics. However, direct observation of 
protein dynamics by imaging can provide relevant information about cellular events that 
cannot be obtained by all the preceding methods. First, imaging can perform in living cells; 
receptor dynamics are measured in a relevant environment. Second, spectrally-resolved 
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fluorophores can identify the distinct cellular components with high specificity. Third, super-
resolution fluorescence imaging can increase in the resolving power at a spatial scale. Thus, 
imaging receptors in living cells is a valuable tool to study dynamics and clustering. In the 
following sections, imaging techniques for measuring receptor dynamics and clustering are 
reviewed. 
Fluorescence recovery after photobleaching (FRAP) 
Fluorescence recovery after photobleaching, known as FRAP, is a matured, but also 
an ever-evolving, fluorescence technique for studying receptor dynamics [26-28]. The basic 
principle is shown in Figure 1.1. High intensity light illuminates a defined region of interest 
(ROI) where the protein under study is tagged with a fluorescent probe. In the bleaching step, 
the fluorophore within the ROI is irreversibly converted into a non-fluorescent species. Then 
the fluorescence intensity within the ROI recovers due to the diffusion of the surrounding 
non-bleached fluorescent probe. The speed and mode of recovery depend upon the diffusion 
of the biomolecule onto which the probe is attached. The fluorescence intensity in the ROI 
before and after the bleaching step is recorded by time lapse microscopy with low intensity 
light. The resulting time-intensity curve is used to obtain the mobile fraction and diffusion 
coefficient. The mobile fraction (R) is defined as:  
 =   −  −             (1 − 1)  
 
where F∞ is the fluorescence intensity in the ROI after full recovery the fluorescence, Fi is the 
fluorescence intensity before the beaching, F0 is the fluorescence intensity just after 
bleaching. The diffusion coefficient (D) is related to the diffusion time, D, and the radius of 
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the focused laser beam is (ω). Each fluorescence recovery curve is further fit with equation 
below [29]. 
() =  +  


1 + 
           (1 − 2)  
 
where the  value after fitting represents the diffusion mode. The diffusion coefficient is 
calculated from:  
 = ω4 (1 − 3) 
There are several photobleaching techniques similar to FRAP such as fluorescence 
loss in photobleaching [30, 31], inverse FRAP [32, 33], fluorescence loss after photo-
activation [34], and fluorescence localization after photobleaching [35]. These techniques 
rely on controlling light illumination on fluorescent proteins or organic dyes. Fluorescent 
proteins such as green, yellow, and red fluorescent protein are ideal in FRAP studies because 
they can be bleached without detectable damage to the cell [36]. Recently, a multi-photon 
FRAP technique was developed for quantitative three-dimensional diffusion measurements 
[37, 38]. Sandra et al. have developed a dual-color FRAP with monomeric and covalent 
dimeric model proteins to identify the dimerization and high-order complexation of receptor 
proteins [39]. FRAP not only provides information about the lateral diffusion of receptors 
within the membrane and dimerization or oligomerization of receptors.  
Fluorescence correlation spectroscopy (FCS) 
Fluorescence correlation spectroscopy, known as FCS, is another popular technique 
to measure the dynamics of molecules on the living cell [40, 41]. FCS is based on the 
statistical analysis of time-dependent intensity fluctuations due to molecules diffusing 
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through a small volume defined by a focused laser illumination and a confocal aperture [42]. 
The basic principle is shown in Figure 1.2. A focal volume is generated by focusing a laser to 
a diffraction-limited spot and confining the spatial scale with a pinhole in the emission path. 
The fluorescence intensity is detected by photon counting devices such as an avalanche 
photodiode [43]. The autocorrelation function, G(), is plotted over the lag time . The 
fluorophores are confined into either two-dimensional (2D) or three-dimensional (3D) planes, 
and the correlation functions for freely diffusing molecules are: 
() = 1 1 +
4
  
           (1 − 4)  
!() = 1 1 +
4
  
 1 + 4"  
           (1 − 5)  
where N is the average number of fluorophores in the detected volume; the radius S and half-
length u refer to distances at which the detection profile decreases to e-2 of its maximal 
intensity value; D is the diffusion coefficient. Recently, a high-throughput FCS was reported 
that reduces the manual, labor-intensive workflow of image optimization, the image 
acquisition, and the correlation analysis [44]. Due to the extreme sensitivity of FCS 
measurement, the magnitude of the diffusional autocorrelation function can measure the 
change of molecular size to large fluorescence spikes and its temporal decay. Tjernberg et al. 
has demonstrated that the formation of amyloid β-protein oligomers precedes the formation 
of fibrils via FCS [45].  
FCS and FRAP are commonly used to measure the diffusion of receptors tagged with 
fluorophores in live cells, and provide similar and often complementary information. 
Traditional FCS methods monitor the intensity fluctuations in a small confocal volume and 
has the benefit of being extremely sensitive to the mobile fluorophores but are not able to 
6 
detect the immobile ones. On the other hand, FRAP can measure the immobile fraction of 
fluorescent molecules [46].  The motion of receptors on the cell membrane is not 
synchronized across the measured region, and the cell membrane is heterogeneous; it is 
essential to measure diffusion one receptor at a time to capture the diffusion heterogeneity. 
Although FRAP and FCS provide millisecond temporal resolutions, the spatial resolutions 
are still not well improved in FRAP and FCS.  In Chapter 1.3, the imaging techniques for 
measuring the receptor dynamics and clustering at the single-protein level and super-
resolution imaging are reviewed.  
 
1.3 Single-molecule Imaging Techniques for Receptor Dynamics and Clustering in 
Living Cells 
Single-molecule imaging has been extensively used to study fundamental protein 
dynamics [47-50]. Single molecule imaging can provide complementary information with 
FCS and FRAP on the diffusion properties of receptors in cell membranes [50]. With modern 
super-resolution advances, single molecule imaging can achieve tens of microseconds 
temporal resolution with down to 1-nm spatial resolution to monitor receptor dynamics and 
membrane organization [51].  
Traditional single particle tracking 
Single particle tracking (SPT) plays a dominant role in many of the advances in 
single-molecule imaging. The proteins of interest are tagged with fluorescent probes such as 
organic dyes [52], fluorescent proteins [53, 54] and quantum dots [55, 56]. Quantum dots 
(Qds) are desirable fluorophores for measuring receptor dynamics because of their high 
quantum efficiency and brightness, which correlate with short acquisition times that lead to 
the fast temporal resolution. The stability of Qds also provides the capability of long analysis 
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durations. Several receptor labeling methods have been reported for SPT measurements. The 
receptors are labeled using either its ligand or antibody [57], which are conjugated with 
fluorophores, or by inserting genes encoding labeling tags such as His-tag [58], Flag-tag [59], 
or Snap-tag [60]. Specific binding is measured to evaluate the efficiency of the labeling 
method.  
After specific labelling has been achieved, the SPT experiments are performed with 
high speed cameras as shown in Figure 1.3. A series of frames showing Qds-labeled protein 
are acquired over time. There are several data analysis options available. For example, a 
2D/3D single-particle tracking plug-in (MosaicSuite) for ImageJ can be used to localize and 
track single particles in each frame over time to generate trajectories of x-y location [61].  
The achieved localization uncertainty may be as low as a few nanometers and depends on the 
signal-to-noise ratio. The algorithm used for the SPT experiments described in this thesis is 
based on the cumulative probability distribution (CPD). CPD is defined as the probability 
that a particle remains within a circle with a radius r. This algorithm has been extensively 
used to quantify the diffusion coefficient and fractional populations in multiple systems [62-
65]. The extracted trajectories are subsequently analyzed using TrackArt, which is a 
MATLAB application based on a previously described algorithm [66, 67]. When the CPD 
reveals there are two or more diffusing populations, the fraction (f) of each population can be 
separately estimated. A single population exhibiting Brownian motion yields a single 
exponential model (1p model) and can be fit by: 
$%(&, ) = 1 − exp +− &4, (1 − 6) 
where D is the diffusion coefficient. The goodness-of-fit is determined by calculating the 
residual sum of squares. If a single exponential model fails to accurately fit the data, then a 
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double exponential model (2p model) is used: 
$%(&, ) = 1 − 〈/ exp +− &40, + (1 − /) exp +−
&
41,〉 (1 − 7) 
The 2p model produces two diffusion coefficients: Df for the fast population and Ds for the 
slow population. The results also provide the relative fractions f and 1 – f for the fast 
population and slow population, respectively [68]. An algorithm developed by Simson and 
Menchon [69, 70] was used to detect confined motion within each trajectory.  Confined 
motion is defined as a diffusive motion that is restricted by boundaries that cannot be crossed 
[71]. The trajectory is analyzed over a specific timeframe and the probability (ψ) of a protein 
diffusing by Brownian motion in the selected time frame is given by 
456(7) = 0.2048 − 2.5117 ×  <=> (1 − 8)
where Dt is the diffusion coefficient, R is the radius of given region. The probability (ψ) is 
then defined as a confinement index (L) by a relation  
? = @− log(7) − 1    7 ≤ 0.1            0               7 > 0.1 (1 − 9) 
The confinement index is able to identify the confined domains in the given trajectory. The 
critical confinement index and critical confinement time are obtained from simulated 
Brownian trajectories for a range of diffusion coefficients as previously described [58]. If a 
trajectory exhibits confined motion, the diffusion coefficient inside confined domains, the 
size of the confined domain, and the time in the confined domain are calculated.  
Super-resolution imaging 
In 2014, the Noble Prize in Chemistry was awarded to three individuals, Eric Betzig, 
Stefan W. Hell and William E. Moerner, who led the super-resolution revolution by breaking 
the diffraction limitation in optical imaging [72]. Super-resolution microscopy techniques are 
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separated into two categories. The first category aims to improve optics and the laser module 
with image processing algorithms and can include the following techniques: structured 
illumination microscopy [73], stimulated emission depletion microscopy (STED) [74], and 
STED derivatives (reversible saturable or switchable optical fluorescence transitions [75, 76], 
and ground state depletion [77]). The second category aims to break the diffraction limit of 
light with stochastic function techniques that control single molecule on-off switching and 
some examples include the following techniques: stochastic optical fluctuation imaging [78], 
stochastic optical reconstruction microscopy (STORM) [79, 80], and photoactivated 
localization microscopy [81-83]. In this dissertation, the results of STORM experiments are 
reported to measure receptor nanoscale organization.  
STORM has been developed as a high-resolution fluorescence microscopy method 
achieved by transferring the number of fluorophores to a reversible dark state and then by 
stochastically activating some certain number of individual fluorophores [84, 85]. The basic 
principle of STORM is shown in Figure 1.4. Photoswitchable fluorophores are used for 
labeling the biomolecule of interest. The fluorophores are switched off upon illumination 
with the appropriate wavelength and intensity of light. Then, a certain number of 
fluorophores are re-activated using another laser wavelength. Usually, 0.1-1.0 fluorophores 
are simultaneously activated per μm2 in order to obtain conditions are suitable for precise 
localization of every fluorophore. Repetitive activation, localization and deactivation lead to 
resolved nanoscale structures in the reconstructed image. The photoswitchable dyes are a key 
element in STORM experiments. Traditionally, organic dyes (such as Alexa Fluor or ATTO) 
require a reducing agent with thiol groups to selectively quench the triplet state [86]. A 
reversible photoswitching process is described as followed. Firstly, fluorophores are excited 
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to a singlet excited state; the excited energy is released to a triplet state; the triplet state 
energy is reduced by thiolate to form radical anions, which are further reoxidized by oxygen 
or through thermal relaxation. These radical anions exhibit a lifetime of several hundred 
milliseconds, which leads to dark events. Recently, our group developed a versatile probe by 
attached paclitaxel to the photoactivatable BODIPY for imaging of microtubules [87].  
Receptors have been reported to form clusters during signal transduction based on 
STORM measurements. For example, Jin et al. have demonstrated that clusters of epidermal 
growth factor receptor measured by STORM exhibit a moderate clustering state with a 
homogeneous distribution on the cell surface of COS-7 cells [88]. Ying et al. have proved the 
multiscale reorganization of T-cell receptors in the immune response by STORM [89]. Sarah 
et al. have discovered two distinct stages of immunoglobulin E receptor clustering in 
response to antigen binding [90]. InChapter 2, STORM data is reported to measure the 
clustering of a receptor for advanced glycation endproducts.  
 
1.4 Receptor for Advanced Glycation Endproducts 
The receptor for advanced glycation endproducts (RAGE) is a member of the 
immunoglobulin superfamily of membrane proteins. It was initially found to be an advanced 
glycation endproducts (AGE)-binding protein [91]. RAGE, as shown in Figure 1.5, contains 
three extracellular immunoglobulin-like domains, a single transmembrane helix domain and 
a cytosolic domain as a tail. The extracellular domain is composed of a V-type and two C-
type domains (C1 and C2). A tandem V-type and C1-type structure (VC1) contributes to 
ligand binding [92]. The short cytosolic tail plays an essential role in signal transduction [93]. 
Many studies indicated that RAGE was thought to be related to a series of chronic disease 
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such as cancer, neurodegeneration, Alzheimer’s, inflammatory response, atherosclerosis and 
diabetes [94-98].  
RAGE, as a pattern recognition receptor, is now prominently characterized as a multi-
ligand receptor that interacts with ligands in addition to advanced glycation endproducts 
including: S100/calgranulins, high mobility group protein box-1 and β-amyloid [99-105]. 
RAGE surface charges show that the VC1 domain displays a positively charged electrostatic 
pocket that attracts the negative character of diverse RAGE ligands by charge-charge 
interactions [106]. RAGE-ligand interactions play an important role in molecular function.   
RAGE oligomerization has been studied by recent fluorescence resonance energy 
transfer, bis(sulfosuccinmidyl) substrate cross-link and X-ray crystallography studies [107, 
108]. The results showed that RAGE forms a hexamer containing a trimer of dimers in 
response to the binding of various ligands [109]. Also, RAGE interacts with intracellular 
protein to perform signal transduction. RAGE signal transduction is a consequence of the 
interaction between the formin homology 1 (FH1) domain of diaphanous-1 (Diaph1) with the 
RAGE cytoplasmic tail [93, 110, 111]. In this dissertation, the effects of extracellular ligands, 
cholesterol levels, and actin polymerization on RAGE diffusion and membrane organization 
are measured via FRAP, SPT and STORM.  
This dissertation is categorized into five chapters. In Chapter 1, a general introduction 
presents a review of the role of receptor dynamics and organization in receptor function as 
well as imaging techniques that can measure receptor diffusion and clusters. The work 
discussed in Chapter 2 describes how Diaph1 affects the nanoscale clustering and lateral 
diffusion of RAGE using SPT and STORM. In Chapter 3, ligand binding affinity and 
changes in the lateral diffusion of RAGE are described at the single receptor level using SPT. 
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The changes in RAGE lateral diffusion and phosphorylation of extracellular signal-regulated 
kinase are described in both native and actin filament altered cells using fluorescence 
recovery after photobleaching in Chapter 4. General conclusions and future insights are 
presented in Chapter 5.  
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1.6 Figures and Tables 
 
Figure 1.1. FRAP images of a Drosophila S2 cells tagged with yellow fluorescence protein. 
Top panel: images from left to right represent pre-bleach, bleach, and recovery after 
bleaching events. Bottom panel: recovery curve measured from the bleach region (red circle 
on the top panel). The red curve is fit using equation (1-2). 
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Figure 1.2. Schematic showing the principle of fluorescence correlation spectroscopy. 
Fluorescent molecules diffusing in and out of a confocal volume result in the intensity 
fluctuations over time ∆. The autocorrelation curve (plot of autocorrelation function G() 
versus lag time ) is calculated as the autocorrelation of the intensity ﬂuctuations and 
measures the self-similarity of the signal.   
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Figure 1.3. Schematic showing the steps in a single particle tracking experiments. (a) A 
series of images of quantum dot-labeled protein of interest is required. The single particles 
are localized in each frame and all the same particles are linked. (b) The trajectory of a single 
particle is plotted in the x-y dimension. An algorithm is applied to detect confined motion in 
a circle with radius R.   
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Figure 1.4. Schematic showing the principle of stochastic optical microscopy. (a) Individual 
receptor is labeled with a fluorophore. All fluorophores are switched to the off state with an 
appropriate wavelength and intensity of laser. A subset of fluorophores is reactivated with a 
lower-power light source. The activated fluorophores are statistically random, and under 
ideal conditions are separated by a distance greater than the diffraction limit of light so that 
the precise position of each fluorophore can be determined. Repeated cycles of activation, 
localization and deactivation are recorded to reconstruct an image. (b) Images of 
microtubules stained in vitro. The left color scale images are generated by single molecule 
localization microscopy. The right gray images are diffraction-limited images generated by 
summing all the frames without localization (Data collected by Chamari Wijesooriya).  
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Figure 1.5. Domain structure of receptor for advanced glycation endproducts (RAGE) in the 
cell membrane with ligands and Diaphanous1 (Diaph1). DID and DAD are the Diaph1 
autoregulatory domain and the Diaph1 inhibitory domain, respectively.  
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CHAPTER 2.    DIAPHANOUS-1 AFFECTS THE NANOSCALE CLUSTERING AND 
LATERAL DIFFUSION OF RECEPTOR FOR ADVANCED GLYCATION 
ENDPRODUCTS (RAGE) 
Modified from a publication on the BBA Biomembranes 
Qiaochu Zhu,1 Emily A. Smith1* 
1Department of Chemistry, Iowa State University, Ames, IA 50011, United States 
 
2.1 Abstract 
The interactions between the cytoplasmic protein diaphanous-1 (Diaph1) and the 
receptor for advanced glycation endproducts (RAGE) drive the negative consequences of 
RAGE signaling in several disease processes.  Reported in this work is how Diaph1 affects 
the nanoscale clustering and diffusion of RAGE measured using super-resolution stochastic 
optical reconstruction microscopy (STORM) and single particle tracking (SPT). Altering the 
Diaph1 binding site has a different impact on RAGE diffusion compared to when Diaph1 
expression is reduced in HEK 293 cells.  In cells with reduced Diaph1 expression (RAGE-
Diaph1-/-), the average RAGE diffusion coefficient is increased by 35 %. RAGE diffusion is 
known to be influenced by the dynamics of the actin cytoskeleton. Actin labeling shows that 
reduced Diaph1 expression lead to the cells with reduced filopodia density and length.  In 
contrast, when two RAGE amino acids that interact with Diaph1 are mutated (RAGERQ/AA), 
the average RAGE diffusion coefficient is decreased by 16 %. Since RAGE diffusion is 
slowed when the interaction between Diaph1 and RAGE is disrupted, the interaction of the 
two proteins results in faster RAGE diffusion. In both RAGERQ/AA and RAGE-Diaph1
-/- cells 
the number and size of RAGE clusters are decreased compared to cells expressing RAGE 
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and native concentrations of Diaph1. This work shows that Diaph1 has a role in affecting 
RAGE clusters and diffusion. 
 
2.2 Introduction 
The receptor for advanced glycation endproducts (RAGE) is a member of the 
immunoglobulin superfamily of cell surface proteins [1, 2], and has been implicated in the 
negative consequences of numerous chronic diseases based on evidence from human and 
animal studies [3-5]. RAGE exhibits promiscuous binding with multiple ligands, including 
S100/calgranulins [4, 6], advanced glycation endproducts [3], high mobility group box 1 [7], 
amyloid A or β peptide [8, 9], and Mac-1/β2 integrin [10]. Interactions between RAGE and 
its ligands are abnormally regulated in Alzheimer’s disease, Parkinson’s disease, diabetic 
neuropathy, inflammatory disease, and cardiovascular disease [11]. In addition, the elevated 
levels of RAGE ligands that may be present as a consequence of these diseases results in 
RAGE upregulation [12]. RAGE may be a good biomarker for many human diseases, and is 
also a potential therapeutic target [13]. There are, however, many missing details about the 
mechanisms that govern the biophysical properties of this important receptor. 
RAGE consists of three extracellular domains, a transmembrane helix, and a short 
cytoplasmic tail. The V-type and C1-type extracellular domains are involved in ligand 
binding, while the C2 extracellular domain supports the rigid V-type/C1-type tandem 
domain. Ligand binding to the extracellular domain of RAGE initiates signal transduction 
[14, 15]. Downstream signaling includes phosphorylation of mitogen-activated protein kinase 
(MAPK), phosphatidylinositol 3-kinase (PI3K/Akt), Rho GTPases (Rac-1 and Cdc42) and 
activation of nuclear factor kappa B (NF- GB) [16-18]. Several of the RAGE ligands are 
multivalent, including the S100/calgranulins (S100B, S100A12). The multivalent binding 
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drives RAGE clusters on the cell surface [6], which is an important aspect of downstream 
signal transduction [15, 16, 19, 20]. Changes in the size of RAGE clusters may affect the 
recruitment of Diaph1 and subsequent signal transduction pathways [21]. Based on data for a 
soluble variant of RAGE, Xie et al. proposed that full-length RAGE on the plasma membrane 
of HEK293T cells may form homooligomers, which would be nanoscale in size (i.e., below 
the diffraction limit of an optical microscope) [14].  
RAGE signal transduction is a consequence of the interaction between the formin 
homology 1 (FH1) domain of diaphanous-1 (Diaph1) with the RAGE cytoplasmic tail [22-
24]. Two amino acids, Arginine-5 (R5) and Glutamine-6 (Q6), of the RAGE cytoplasmic tail 
are essential for interactions with Diaph1 based on the lack of binding for a R5A/Q6A RAGE 
mutant [25]. When Diaph1 expression is reduced via RNA interference, RAGE singling 
through Akt is blocked and the migration of SMC cells is suppressed [22, 26]. Diaph1 plays 
an essential role in regulating a variety of cytoskeleton-dependent cellular processes under 
stimulation including actin and microtubule polymerization as well as the formation of 
filopodia for vesicle trafficking [27-31] Under non-stimulating conditions, Diaph1 controls 
cellular adhesion by stabilizing microtubules for localized clustering of integrin-β1 at the 
plasma membrane [32].  
Although the cytoplasmic interactions between RAGE with Diaph1and the resulting 
signaling pathways have been studied, the effect of Diaph1 on RAGE diffusion and 
nanoscale clusters remains unknown. These properties can affect biomolecular interactions, 
signal transduction and overall cellular function [33-35].  In order to provide this missing 
information, single particle tracking (SPT) is used to individually track the diffusion of a 
subset of diffusely-labeled receptors and to test the role of Diaph1 in affecting RAGE 
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diffusion. In addition, the size of RAGE nanoscale clusters is measured using super-
resolution stochastic optical reconstruction microscopy (STORM). Disrupting the interaction 
between RAGE and Diaph1 through protein mutation results in different RAGE clustering 
and diffusion properties compared to when Diaph1 expression is reduced altogether. The 
latter may be the result of disrupting the actin cytoskeleton when Diaph1 expression is 
reduced.  This conclusion is supported by previous reports where we show that RAGE 
diffusion is altered by compounds that inhibit actin depolymerization [36]. 
 
2.3 Materials and Methods 
Cell culture, actin staining, and filopodia quantification 
Details of RAGE plasmid construction, down-regulation of Diaph1, Western blotting 
and RT-PCR methods are provided in the supplementary material. Cells were plated onto an 
8-well NuncTM Lab-TekTM chambered glass slide. For intracellular actin staining in HEK293 
cells, cells were fixed with 4% paraformaldehyde (Sigma Aldrich) in PBS for 30 min at room 
temperature after rinsing cells with phosphate buffered saline (PBS) three times. Cells were 
washed twice with 1 mg/mL sodium borohydride (Fisher Chemical) in PBS for 5 min to 
quench cellular autofluorescence. The cells were permeabilized with 0.1% Triton-X100 
(Thermo Scientific) in PBS for 5 min, and the actin filaments were stained using Alexa Fluor 
488 phalloidin (1:100) (InvitrogenTM) in PBS for 30 min. After rinsing the cells with PBS, 
they were imaged by using a Leica TCS SP5 confocal microscope with a 100×-magnification 
1.4-NA oil-immersion objective. Images were collected with a frame rate of 200 Hz and 400 
nm z-step size. The ImageJ plugin FiloQuant was used to quantify the filopodia length and 
density [37, 38]. The filopodia density is defined as the ratio of the number of filopodia per a 
given length of the cell edge. 
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STORM and clusters analysis 
An 8-well NuncTM Lab-TekTM chambered glass slide was sonicated in 1M KOH for 
15 min then rinsed with deionized water. The glass slide was coated with 0.01% poly-l-lysine 
solution then washed with deionized water and dried under ultraviolet radiation. Cells were 
subcultured onto the glass slide until 60% confluence was achieved. The cells were washed 
with PBS twice then fixed with 1% paraformaldehyde for 10 min at room temperature. After 
three PBS washes, the cells were incubated with anti-RAGE antibody (1:100) in incubation 
buffer (5% normal goat serum (InvitrogenTM) and 1% BSA prepared in PBS solution) for 1h 
at room temperature. The RAGE primary antibody interacts with the extracellular domain of 
RAGE. The cells were washed with incubation buffer three times and then incubated with 
Alexa Fluor 647 F(ab')2-Goat anti-rabbit (A21246, InvitrogenTM) (1:1000) for 30 min at 
room temperature. After three PBS washes, 800 μL of imaging buffer (50 mM NaCl, 10% 
glucose, 0.5 mg/mL glucose oxidase, 40 μg/mL catalase, and 50 mM cysteamine in 10 mM 
Tris, pH = 8.0) were added into each well then covered by a glass coverslip. The labeling 
conditions used in this study ensure that the signal is coming only from receptor in the 
membrane. No detectable labeling was measured for HEK293 cells that lack the expression 
of exogenous RAGE. For STORM experiments, a Nikon TE2000U epifluorescence/TIRF 
microscope equipped with a 100× 1.49 NA oil immersion objective and a 635-nm excitation 
laser (LQC635, CW laser diode, Newport) with a power density of 1.5 KW/cm2 were used. 
Movies were collected with 15,000 frames, a 40 ms exposure time, and a 64×64 frame size 
using a EMCCD (Andor iXonEM+ DU-897).  The ImageJ plugin ThunderSTORM was used 
to localize single molecules in each frame of the movie and to construction super resolution 
images [39]. Briefly, the size of each pixel (0.16 μm/pixel), photoelectrons per A/D count 
EM gain (600), exposure time (40 ms) were used as inputs for the camera settings. Single 
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molecules were localized using weighted least-squares fitting of an integrated Gaussian PSF 
enabled to detect up to two single molecules within a diffraction-limited area. The 
localization precision and Ripley’s K analysis were performed using LocAlization 
Microscopy Analyzer (LAMA) [40].  
Single particle tracking 
Cells were subcultured onto 8-well NuncTM Lab-TekTM chambered glass slides that 
were coated with 0.01% poly-L-lysine solution (P4704, Sigma Aldrich) for 48 h. The 
medium was changed to 3% BSA in DMEM for 18 h to coat any remaining glass surface. 
The anti-HA labeled QDs (AHA-QDs) were prepared as previously published [41]. After 100 
pM AHA-QDs were diluted in imaging buffer (20 μM HEPES, 6 μM D-glucose, 0.3 μM 
Na2HPO4, 138 μM NaCl, 4 μM NaHCO3, 0.4 μM KH2PO4, 5 μM KCl, 0.4 μM MgSO4･
7H2O, 0.5 μM MgCl2･6H2O, 1 μM CaCl2) with 0.1% BSA, cells were incubated with AHA-
QDs for 15 min at 37 °C. This labeling method is highly specific to cells expressing RAGE. 
In Figure S2.1, there is an average of 2 ± 1 QDs per wild-type HEK293 cell that does not 
have detectable levels of RAGE as measured by Western blot analysis. The QDs measured in 
wild-type HEK293 cells exhibit no movement within the uncertainty of the localization 
measurement, and have an average diffusion coefficient less than 0.0018 μm2/s. In cells 
expressing transgenic RAGE, an average of 20 ± 10 QDs per cell is bound to the cell (Figure 
S2.1). In order prevent skewing the SPT results with signals that may correspond to QDs not 
bound to RAGE (nonspecific binding), only trajectories that result in a RAGE diffusion 
coefficient larger than 0.0018 µm/s were considered.  
Cells were washed with imaging buffer before performing microscopy experiments. 
SPT experiments were performed at 37 °C with an Eclipse Nikon (TE2000U) microscope in 
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wide-field, epi-mode with a 100× 1.4 NA oil-immersion objective. The light from a mercury 
lamp was passed through a filter set (excitation: 425/25 nm; emission: 605/20 nm; Omega 
Optical. The signal was collected by an Andor iXonEM+ DU-897 back-illuminated electron-
multiplying charge coupled device (EMCCD) with a 40 ms acquisition time and 700 frames 
were collected. A 2D/3D single-particle tracking plug-in (MosaicSuite) for ImageJ was used 
to track single particles in each frame over time to generate trajectories of x-y location [41-
43].   
More than 150 single particle trajectories from at least 20 cells were collected for 
each cell line, and were subsequently analyzed using TrackArt, which is a MATLAB 
application based on a previously described algorithm [44, 45]. To quantify RAGE diffusion 
on the ensemble level, the mean square displacement (MSD, r2) was determined by the 
cumulative probability distribution (CPD) of the square displacement over consecutive time 
lags (4s). This method has been extensively used to quantify the diffusion coefficient and 
fractional populations in multiple system [46-49]. CPD is defined as the probability that a 
particle remains within a circle with a radius r. The fraction (f) of each population can be 
separately estimated. A single population exhibiting Brownian motion yields a single 
exponential model (1p model) and can be fit by: 
$%(&, ) = 1 − exp (− &4) 
where D is the diffusion coefficient. The goodness-of-fit was determined by calculating the 
residual sum of squares. If a single exponential model failed to accurately fit the data, then a 
double exponential model (2p model) was used: 
$%(&, ) = 1 − 〈/ exp +− &40, + (1 − /) exp +−
&
41,〉 
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The 2p model produces two diffusion coefficients: Df for the fast population and Ds for the 
slow population. The fit results also provide the relative fractions f and 1 – f for the fast 
population and slow population, respectively [50].  
The MATLAB APM_GUI based on an algorithm developed by Simson and Menchon 
[51, 52] was used to detect confined motion within each trajectory.  Confined motion is 
defined as diffusive motion that is restricted by boundaries that cannot be crossed [53]. 
Within the confinement boundaries, Brownian diffusion may occur. Briefly, all trajectories 
were categorized as either Brownian motion or non-random (i.e., confined) motion based on 
the probability (L) of staying within a region of radius R. The critical confinement index (Lc) 
and critical confinement time (tc) were obtained from simulated Brownian trajectories for a 
range of diffusion coefficients as previously described [41]. A trajectory with Lc > 3.16 and 
tc > 1.95 is categorized as confined motion. If a trajectory exhibits confined motion, the 
diffusion coefficient inside confined domains (Din), the size of the confined domain (R), and 
the time in the confined domain (t) were calculated.  
Statistical analysis 
The reported data was determined to exhibit a parametric distribution or non-
parametric distribution using the Shapiro-Wilk Test for normality. The statistical significance 
of all parametric distributions was calculated using the F-test at the 95% confidence level and 
then a paired/unpaired (as determined by the F-test) Student’s t-test with a two-tailed 
distribution. The statistical significance of all non-parametric distributions was calculated 
using the Mann-Whitney test with a two-tailed distribution.  All resulting p-values below 
0.05 are reported in the figures. If a p-value was not reported, its value was greater than 0.05 
unless otherwise noted in the figure legend. 
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2.4 Results and Discussion 
RAGE forms nanoscale clusters that are altered when Diaph1 expression is reduced or 
when the interaction between Diaph1 and RAGE is altered 
To measure RAGE clusters and diffusion under conditions of altered interaction with 
Diaph1, stably transfected HEK 293 cells were developed that expressed RAGE or RAGE 
with a R5A/Q6A mutation on the cytoplasmic tail (RAGERQ/AA). The amino acid sequence in 
the transmembrane domain and intracellular domain of RAGE and RAGERQ/AA are shown in 
Figure S2.2a. An HA epitope was added to the extracellular domain of all RAGE sequences 
to facilitate specific labeling with an HA antibody. It has been shown that the cell signaling 
measured by phosphorylation of ERK is not altered in cells expressing RAGE with and 
without the HA epitope [41].  
Diffraction-limited wide-field fluorescence images show a fairly uniform RAGE 
distribution throughout the cell membrane with a higher signal around the periphery of the 
cell (Figure 2.1a). STORM allows the RAGE distribution to be measured with 21-nm 
localization precision as determined by nearest-neighbor-based analysis. In Fig.1b and Fig.1c, 
RAGE clusters of varying size are observed; clusters are also measured for cells expressing 
RAGERQ/AA (Figure S2.3). The amount and size of the clusters is quantified using Ripley’s 
K-function analysis (Figure 2.1d).  The integrated areas of the Ripley’s K-function curves 
indicate there are more RAGE clusters compared to RAGERQ/AA clusters. In addition, RAGE 
has clusters as large as 760 nm, however, RAGERQ/AA does not exhibit clusters larger than 
610 nm (i.e., there is a random distribution over a longer length scale). This shows that 
altering the interaction between RAGE and Diaph1 also alters the amount and size of RAGE 
clusters in HEK 293 cells. A previously reported NMR structural analysis showed that 
increasing the molecular dimension of RAGE resulted in recruiting Diaph1 and initiating 
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signal transduction [21]. When Diaph1 is not recruited due to altering the interaction between 
Diaph1 and RAGE, both RAGE clustering and its associated signal transduction pathways 
may be altered. 
The influence of Diaph1 on RAGE clusters was further analyzed in a cell line with 
reduced Diaph1 expression (RAGE-Diaph1-/-). The concentration of Diaph1 is reduced, but 
not eliminated in these experiments, as shown in Figure S2.2c and Figure S2.2d. Diaph1 is a 
formin family protein, and is known to affect the formation of actin filaments [28]. In order 
to confirm the reduced levels of Diaph1 achieved in this study had a similar effect on the 
actin cytoskeleton as previously reported, phalloidin staining of the actin cytoskeleton was 
measured (Figure 2.2a). As shown in Figure 2.2b-2.2c, the filopodia density                     
(0.24 ± 0.05 μm- 1) and length (2.1 ± 0.2 μm) increase in cells expressing RAGE when 
compared to wild-type HEK 293 cells that do not express exogenous RAGE. This is 
consistent with previous reports [54]. The filopodia density and length decrease by 61% and 
37%, respectively, in RAGE-Diaph1-/- cells compared with cells expressing both RAGE and 
Diaph1. After Diaph1 expression is reduced, the values are statistically the same as those 
measured for cells that do not express transgenic RAGE, indicating that the increased 
filopodia length and density resulting from RAGE expression can be eliminated by reducing 
the expression of Diaph1. In RAGERQ/AA cells, the filopodia density and the filopodia length 
are decreased compared to cells expressing RAGE. This indicates that alterations to the actin 
cytoskeleton also occur in the cell line where the interaction between Diaph1 and RAGE is 
blocked, although the alterations are not as pronounced as when Diaph1 expression is 
reduced.  
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Fewer RAGE clusters are measured in the RAGE-Diaph1-/- cell line compared to cells 
expressing native Diaph1 levels (Figure 2.1d), which is consistent with the data for cells 
expressing RAGERQ/AA. The RAGE-Diaph1
-/- cell line, however, exhibits a larger amount of 
smaller clusters.  Also, the largest cluster size is 510 nm in the RAGE-Diaph1-/- cell line, 
which is smaller than the value for RAGERQ/AA. Reducing the concentration of Diaph1 and 
disrupting its interaction with RAGE produce both fewer and smaller RAGE clusters 
compared to the control cell line, but there may be distinct mechanisms for how the RAGE 
clusters are altered in these cell lines.  
RAGE diffusion in HEK 293 cells is altered differently when Diaph1 expression is 
reduced compared to when the Diaph1 binding site is altered 
RAGE diffusion was measured in HEK 293 cells using SPT. First a cumulative 
probability distribution (CPD) analysis of the trajectories was performed to determine the 
number of diffusing populations that could be measured as well as the diffusion coefficient of 
each population. Next the properties of transient confinement within each trajectory were 
measured to obtain the diffusion coefficient and residence time in confined domains as well 
as the sized of the confined domains.  
As shown in Figure 2.3a-2.3b, RAGE diffusion (i.e., mean square displacement 
versus probability plot) is better fit by a model with two populations (2p model) than a model 
with one population (1p model). The two populations will be referred to as the fast fraction 
and slow fraction. The diffusion coefficient for each population can be obtained from a fit to 
the MSD versus time plot (Figure 2.3d-2.3e). There is no statistically significant difference 
between the fit for Brownian diffusion and anomalous motion for either the fast or the slow 
population, thus the simpler Brownian fit was used to quantify the diffusion coefficients. The 
RAGE diffusion coefficients for the fast (Df) and slow (Ds) population are 0.107 μm
2/s and 
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0.0149 μm2/s, respectively. A 72% majority of the RAGE exhibits fast diffusion (Figure 
2.3c).  
The cumulative probability distribution curve for RAGERQ/AA and RAGE-Diaph1
-/- 
are also best described using a 2 population model (Figure S2.4a-2.4b, Figure S2.5a-2.5b). 
All fit results are summarized in Figure 2.4. Both the fast and slow diffusion coefficient for 
RAGERQ/AA show a statistically significant decrease to 0.094 μm
2/s and 0.011μm2/s, 
respectively, compared with the diffusion coefficients for RAGE (Figure 2.4b-Figure 2.4c). 
The interaction between RAGE and Diaph1 increases RAGE diffusion, which is slower when 
the RAGE/Diaph1 interaction is blocked at the known binding site on RAGE. 
When Diaph1 expression is reduced, there is an increase in the fast diffusion 
coefficient for RAGE to 0.162 μm2/s (Figure 2.4b), which may be the result of disrupting the 
protein interaction (or possibly a protein complex) or it may be the result of the altered 
cytoskeleton (Figure 2.2). In a previous study, we showed the RAGE diffusion coefficient 
decreased by 37 % when actin filament depolymerization is inhibited by treatment with 
jasplakinolide in GM07373 cells [36]. Considering this previous finding, it is not surprising 
to measure a 35 % increase in the average RAGE diffusion coefficient when actin 
polymerization is reduced by the lower expression levels of Diaph1. It is proposed that the 
population of RAGE with a faster diffusion coefficient is impacted by the structure of the 
actin cytoskeleton, which is why this population has a faster diffusion coefficient when 
Diaph1 expression is reduced. 
RAGE diffusion exhibits transient events that represent diffusion within confined 
domains (Figure S2.6). Additional information about RAGE diffusion within confined 
domains can be obtained from analyzing the local displacement of segments of each 
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trajectory. The average diffusion coefficient of RAGE in confined domains (Din) is 0.018 
μm2/s (Figure 2.5a). The average diffusion coefficient of RAGERQ/AA within confined 
domains is statistically lower (0.013 μm2/s). Both the magnitude of the diffusion coefficient 
as well as the relative decrease when comparing the diffusion coefficients for RAGE and 
RAGERQ/AA suggest that the slow population from the CPD analysis may represent those 
receptors that are diffusing within confined domains. Coincident with the decrease in the 
diffusion coefficient for RAGERQ/AA in confined domains, there is also a decrease in the size 
of the confined domains (0.18 μm) compared to RAGE (0.23 μm) (Figure 2.5b). For all other 
cellular conditions, the differences in the diffusion coefficient and size of confined domains 
were not statistically significant (p > 0.02). (Figure 2.5c). 
 
2.5 Conclusions and Future Insights 
Diaph1 affects RAGE clusters and RAGE’s diffusion properties. Reducing the 
expression of Diaph1 and eliminating the binding site to RAGE have similar effects on 
reducing the size and number of RAGE clusters, but do not have the same effects on RAGE 
diffusion. Decreased RAGE diffusion is only measured when the known site of interaction 
with Diaph1 is altered on the RAGE cytoplasmic tail. Both the fast and slow populations are 
affected, and the changes to the slow population may correlate with alterations to properties 
of confined domains in the membrane. Reducing the expression of Diaph1 increases RAGE 
diffusion; the mechanism is proposed to involve the concomitant changes to actin 
polymerization.  This shows that Diaph1 can affect RAGE diffusion and clusters, and that 
these properties are influenced by the intracellular environment.  
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2.7 Figures and Tables 
 
Figure 2.1. RAGE spatial organization in the plasma membrane of HEK 293 cells as 
measured by fluorescence microscopy. (a) Wide-field diffraction-limited image measured by 
primary anti-RAGE antibody with Alexa Fluor 647 F(ab')2-Goat anti-rabbit secondary 
antibody. The white box represents the region where STORM measurements were performed. 
The scale bar is 10 μm. (b) Reconstructed STORM image. The white box represents the 
region where cluster analysis was performed. Scale bar is 10 μm. (c) Heat map showing the 
results from cluster analysis of a (4 μm × 4 μm) region. The color indicates the degree of 
clustering from low (dark blue) to high (red). (d) Plots of Ripley’s K-function analysis of the 
clustering properties of RAGE, RAGERQ/AA, RAGE-Diaph1
-/- in HEK293 cells (n = 4 for 
each cell type). L(r)-r represents the clustering ability, and r represents the radial clustering 
scale.   
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Figure 2.2. Filopodia density and length measured when the actin cytoskeleton is stained 
with Atto 647N-conjugated phalloidin in HEK 293 cells. The number of analyzed HEK293 
cells are: wild-type (WT) cell line (n = 8), cells expressing RAGE (n = 10), cells expressing 
RAGERQ/AA (n = 13), RAGE-Diaph1
-/- cells (n = 15). (a) The filopodia detected using 
FiloQuant are labeled with a pink line in each image. Box plots of (b) the filopodia density 
and (c) filopodia length. The line inside the box represents the mean value. The box shows 
the twenty-fifth and seventy-fifth quartiles with the mean shown within the box. The thin line 
is 1.5 times the interquartile range.   
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Figure 2.3. RAGE diffusion properties obtained from all trajectories (n = 130) measured in 
HEK 293 cells. The average of all trajectories’ cumulative probability distribution (CPD) 
with a 4 sec lag time versus squared step sizes (r2) are fit using (a) single population model 
(1p) and (b) two population model (2p). The grey dashed line represents the CPD, the solid 
black line represents the fit curve. (c) Fractions of the fast population and slow population 
calculated using the 2p model. The average MSD plots for the (d) fast and (e) slow 
population versus lag time. The black lines represent the fit curves.  
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Figure 2.4. Average diffusion properties of RAGE (n = 145), RAGERQ/AA (n = 185), RAGE-
Diaph1-/- (n = 131) in HEK 293 cells. (a) Fraction of the total RAGE exhibiting both fast 
diffusion and slow diffusion, and the diffusion coefficient for (b) the fast population (Df) and 
(c) the slow population (Ds) obtained from a double exponential fit to the cumulative 
probability distributions. (d) Average diffusion coefficient for the sum of both Df and Ds 
multiplied by their individual fraction. The error bars represent the standard error in the fit. 
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Figure 2.5. Analysis of all the trajectories exhibiting confined motion in HEK 293 cells. The 
number of analyzed confined domains are RAGE (n = 140), RAGERQ/AA (n = 182), RAGE-
Diaph1-/- (n = 91). Violin plot of the (a) negative natural log of the diffusion coefficients 
within confined domains, (b) size of confined domains, and (c) duration of time in confined 
domains. The width of the violin plot represents the data distribution. Overlapping each 
violin plot is a box plot showing the mean (white dot) of all values within the data set. The 
solid line shows the twenty-fifth and seventy-fifth quartiles. The thin line is 1.5 times the 
interquartile range. p-values were obtained from the Mann-Whitney test (non-parametric 
distribution).  
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2.8 Supporting Information 
DNA construction 
The expression vector for RAGE labeled with a hemagglutinin (HA) tag 
(pcDNA3.HARAGE) has been previously described [1]. Briefly, the HA tag (amino acid 
sequence YPYDVPDYA) was inserted into the N-terminal of RAGE after the signal 
sequence of a previously developed pcDNA3.RAGE vector [1] using sense primer 5’-
TACCCGTACGACGTGCCGGACTACGCCATCACAGCCCGGATTGGC-3’ and anti-
sense primer 5’-GGCGTAGTCCGGCACGTCGTAGTTTTGAGCACCTACTACTGCCC-
3’. The plasmid for expressing RAGE with a R5A/Q6A cytoplasmic domain mutation 
(pcDNA3.HARAGERQ/AA) was generated by site-directed point mutagenesis using sense 
primer 5’-AGGGCAGCACGCCGAGGAGAGGAGAGGAAG-3’ and anti-sense primer 5’-
ACGCTCCTCCTCTTCCTCCTGGTTTTCTGG-3’. After PCR-amplification and Dipn1 
enzyme digestion, a Gibson assembly master kit (New England Biolabs Inc.) was used to 
ligate all the fragments. All plasmids contained the desired sequences as confirmed by DNA 
sequence analysis. The resulting RAGE amino acid sequences in the transmembrane domain 
and intracellular domain for each of these plasmids are shown in Figure S2.2a. 
Cell culture, transfection and CRISPR/Cas9  
HEK293 cells from the American Type Culture Collection (ATCC, CRL-1573) were 
maintained in Dulbecco’s modified Eagle’s medium (DMEM) (Sigma Aldrich) 
supplemented with 10% fetal bovine serum, 1% penicillin-streptomycin at 37 °C and 5% 
CO2 in a humidified atmosphere. HEK293 cells were transfected with purified recombinant 
plasmid using Lipofectamine 3000 (InvitrogenTM). For the generation of stable cell lines 
expressing RAGE or RAGERQ/AA, 800 μg/mL geneticin G418 (Santa Cruz Biotechnology) 
was used to initiate selectin of antibiotic-resistant cells. For the maintenance of stably 
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transfected cell lines, the concentration of G418 was decreased to 400 μg/mL. Protein 
expression was confirmed by Western blot analysis (Figure S2.2b and S2.2c). All the cell 
lines expressing full-length RAGE exhibit an expected band at 55 kDa. Transgenic RAGE 
expression is higher than measured for wild-type cells without transgenic RAGE expression. 
To establish RAGE-Diaph1-/- HEK293 cells lacking the expression of Diaph1, 
pSpCas9-Diaph1-sgRNA(GenScript) (sgRNA sequence: TGTTGTTGAGAGACACACGA) 
was transfected into RAGE cells using Lipofectamine 3000.  Cells were selected with 0.4 
μg/mL puromycin. To maintain the RAGE-Diaph1-/- HEK293 cell line, 0.2 μg/mL 
puromycin and 200 μg/mL G418 were used. There is a 7-fold reduction in Diaph1 expression 
(Figure S2.2b), and a 20-fold reduction in Diaph1 mRNA in RAGE-Diaph1-/- cells compared 
to the RAGE cell line (Figure S2.2c). 
Western blotting and RT-qPCR 
Wild-type HEK293 cells and cells expressing RAGE, RAGERQ/AA, or RAGE-Diaph1
-
/- were subcultured into a 6-well plate for 48 hrs. After the cells were rinsed with phosphate 
buffered saline (PBS) three times, cells were lysed by adding lysis buffer (50 mM Tris pH 
7.5, 120 mM NaCl, 0.5% NP40) containing 1× Halt protease inhibitor cocktail 
(InvitrogenTM). The protein concentration of cell lysates were quantified using a protein BCA 
assay kit (InvitrogenTM). 15 μg protein was electrophoresed using a NuPAGE Novex 4-12% 
Bis-Tris protein gel (NovexTM) followed by electro blotting to PVDF membrane 
(InvitrolonTM, 0.45 μm pore size) for 4 hrs. The membrane was blocked with 5% bovine 
serum albumin for 1 hr at 37 °C, and then RAGE and Diaph1 expression were probed using 
anti-RAGE rabbit (17H19L10, InvitrogenTM), anti-Diaph1 mouse (sc-373807, Santa Cruz 
Biotechnology), anti-vinculin goat (sc-7649, Santa Cruz Biotechnology), and anti-Actin 
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rabbit (sc-1616-R, Santa Cruz Biotechnology). The labeled secondary antibodies were Alexa 
Fluor 647 goat anti-rabbit (Life technologies), Alexa Fluor 488 donkey anti-goat (Life 
technologies), and Alex Fluor 488 goat anti-mouse (Life technologies). The fluorescence 
intensity was measured with a Typhoon FLA 95000 variable mode laser imager (GE 
Healthcare). The actin and vinculin protein bands were used as loading controls in the 
Western blot experiments.  
mRNA was isolated using a Dynabeads mRNA DIRECT kit (InvitrogenTM) following 
the manufacturer’s instruction. For reverse transcription, 500 ng mRNA was converted to 
complementary DNA using a High Capacity RNA-to-cDNA Kit (Applied Biosystems). 
Quantitative real-time PCR analysis was performed using Applied Biosystems TaqMan Gene 
Expression assays (ACTB as housekeeping gene: Hs01060665_g1; Diaph1: Hs00946567_g1; 
AGER: Hs00542592_g1) on a Roche Light Cycler 480 system (Roche Applied Science). The 
comparative cycle threshold (CT) was used to determine relative mRNA expression of the 
genes as normalized by a ACTB housekeeping gene. The level of gene expression was 
determined by the 2-∆∆CT method [2].  
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Figures and tables for supporting information for Chapter 2 
 
Figure S2.1. Quantification of the average number of quantum dots (Qds) in HEK 293 cells 
(n = 35). Histograms of the average number of Qds per cell for wild type cells (WT, wherein 
no RAGE is detected by Western blot) and RAGE expressing cells: RAGERQ/AA, and RAGE-
Diaph1-/- with a reduced expression of Diaph1 (Bin size = 5).  
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Figure S2.2. Quantification of protein and mRNA expression in HEK 293 cell lines. (a) 
Amino acid sequence of RAGE and RAGERQ/AA in the transmembrane and intracellular 
domains. Western blot analysis of (b) RAGE protein expression and (c) Diaph1 protein 
expression. Diaph1 expression is not eliminated in the RAGE-Diaph1-/- cell line, which may 
be the result of incomplete selection of transfected cells. Fluorescence images of the PVDF 
membrane were detected with primary RAGE, vinculin, Diaph1, actin antibody and Alexa 
Fluor labeled secondary antibody. Average fluorescence intensities (n = 3) of the RAGE and 
Diaph1 bands were divided by the vinculin and actin bands, respectively. The Wild type 
(WT) HEK293 cell line was used to normalized the fluorescence intensity of the other cell 
lines. Since Western blotting does not provide an absolute concentration, it is unclear that 
any differences in RAGE expression measured by Western blotting have a significance in the 
membrane environment. (d) Average (n = 3) change in the mRNA level of Diaph1 
determined by RT-qPCR. The relative gene expression was normalized by beta actin (ACBT) 
as the internal control, and analyzed using the 2-∆∆CT method. ** represents p-value < 0.01; 
*** represent p-value < 0.001.  
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Figure S2.3. Reconstructed storm images showing the spatial organization in the plasma 
membrane of (a) RAGERQ/AA, and (c) RAGE-Diaph1
-/-. The 4 μm × 4 μm white box 
represents the region where cluster analysis was performed, and the results are shown in the 
heat map to the right of each image in (b) and (d). The color indicates the degree of 
clustering from low (dark blue) to high (red). The background (possibly from cellular 
autofluorescence) varies from cell to cell (i.e., image to image). Scale bar is 10 μm. 
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Figure S2.4. Analysis of RAGERQ/AA diffusion properties obtained from all trajectories (n = 
180) measured in HEK 293 cells. The average cumulative probability distribution (CPD, gray 
dashed line) of all trajectories with a 4 sec lag time versus squared step size (i.e., r2). The fit 
using (a) a single population (i.e., 1p) and (b) two populations (i.e., 2p) models is shown as 
the solid black line. (c) Fractions of the fast (red) and slow (blue) populations calculated 
using the 2p model. The average MSD versus lag time plots for the (d) fast and (e) slow 
population. The black line in (d) and (e) represents the fit to the data, which is used to 
calculate the diffusion coefficient for each population. 
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Figure S2.5. Analysis of RAGE-Diaph1-/- diffusion properties obtained from all trajectories 
(n = 131) measured in HEK293 cells. The average cumulative probability distribution (CPD, 
gray dashed line) of all trajectories with a 4 sec lag time versus squared step size (i.e., r2). 
The fit using (a) a single population (i.e., 1p) and (b) two populations (i.e., 2p) models is 
shown as the solid black line. (c) Fractions of the fast (red) and slow (blue) populations 
calculated using the 2p model. The average MSD versus lag time plots for the (d) fast and (e) 
slow population. The black line in (d) and (e) represents the fit to the data, which is used to 
calculate the diffusion coefficient for each population. 
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Figure S2.6. Two examples of RAGE single particle trajectories that exhibit transient events 
that represent diffusion within confined domains. All trajectories (blue line) were categorized 
as either Brownian motion or confined (i.e., non-random) motion based on the probability (L) 
of staying within a region of radius R (represented by the red circle). If the critical 
confinement index (Lc ) is greater than 3.16 and critical confinement time (tc) is greater than 
1.95, values obtained from simulated Brownian trajectories for a range of diffusion 
coefficients as previously described [3], a trajectory is categorized as confined motion. 
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3.1 Abstract 
The effect of ligand on the lateral diffusion of receptor for advanced glycation 
endproducts (RAGE), a receptor involved in numerous pathological conditions, remains 
unknown. Single particle tracking experiments that use quantum dots specifically bound to 
hemagglutinin (HA)-tagged RAGE (HA-RAGE) are reported to elucidate the effect of ligand 
binding on HA-RAGE diffusion in GM07373 cell membranes. The ligand used in these 
studies is methylglyoxal modified-bovine serum albumin (MGO-BSA) containing advanced 
glycation end product modifications. The binding affinity between soluble RAGE and MGO-
BSA increases by 1.8 to 9.7-fold as the percent primary amine modification increases from 
24 to 74% and with increasing negative charge on the MGO-BSA. Ligand incubation affects 
the HA-RAGE diffusion coefficient, the radius of confined domains of diffusion, and 
duration in confined domains of diffusion. There is, however, no correlation between MGO-
BSA ligand binding affinity and the extent of the changes in HA-RAGE lateral diffusion. 
The ligand induced changes to HA-RAGE lateral diffusion do not occur when cholesterol is 
depleted from the cell membrane, indicating the mechanism for ligand-induced changes to 
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HA-RAGE diffusion is cholesterol dependent. The results presented here serve as a first step 
in unraveling how ligand influences RAGE lateral diffusion. 
 
3.2 Introduction 
The receptor for advanced glycation endproducts (RAGE) is a transmembrane 
receptor that is involved in several pathological disorders [1-3]. It is a multi-ligand pattern-
recognition receptor with a diverse array of chemically distinct ligands [4]. Although ligand 
induced RAGE signaling has been studied extensively in various pathological states, 
knowledge of the molecular diffusion of RAGE in the cell membrane is generally unknown. 
The lateral diffusion of membrane proteins plays a role in how receptors interface with other 
membrane proteins, extracellular ligands, and intracellular proteins, and more generally, how 
receptors function. The goal of the work reported herein is to understand the effect of ligand 
incubation on the lateral diffusion and signaling of RAGE in GM07373 bovine artery 
endothelial cell membranes.  
RAGE consists of one variable (V) and two constant (C1 and C2) domains in the 
extracellular region, a single transmembrane domain and a short cytoplasmic tail. The RAGE 
extracellular ligand binding domains belong to the immunoglobulin superfamily. RAGE 
interacts with several ligands including advanced glycation endproducts (AGE), members of 
the S100/calgranulins family of proteins and amyloid-beta peptides [5-7]. AGE include non-
enzymatic modifications of surface amino acid residues lysine, arginine and cysteine, which 
may lead to protein cross linking. The resulting AGE-modified proteins have a net increase 
in negative surface charge [8]. Although RAGE ligands are structurally different, all ligands 
are reported to contain negatively charged regions that are important for binding. Structural 
analysis of the RAGE extracellular domain with X-ray crystallography and nuclear magnetic 
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resonance spectroscopy corroborates the notion that negatively charged ligands interact with 
positively charged surfaces of the V and C1-type RAGE ectodomains [9, 10]. The binding 
between RAGE and its ligands has been measured by several techniques including surface 
plasmon resonance (SPR) and ELISA. For example, the dissociation constants measured by 
SPR with human RAGE were 360 nM and 1.3 µM for glceraldehyde-derived and 
glycoladehyde-derived AGE, respectively [11]. A SPR analysis of the S100B-soluble RAGE 
interaction revealed a moderate affinity with an 8.3 µM dissociation constant [12]. 
Methylglyoxal modified-bovine serum albumin (MGO-BSA, a model AGE similar to the one 
used herein), binds to the V domain of RAGE with an 800 nM dissociation constant as 
measured by ELISA [13].  
We have recently reported properties of RAGE lateral diffusion as measured by 
fluorescence recovery photobleaching (FRAP) [14]. The lateral diffusion of RAGE and 
RAGE-dependent signaling were found to be connected to the dynamics of the actin 
cytoskeleton. In a FRAP experiment, the measured diffusion parameters represent an 
ensemble average of numerous receptors. However, receptor lateral diffusion is generally not 
synchronized across each receptor, and the heterogeneity of all possible diffusion behaviors 
is not measured by FRAP. For this purpose, it is necessary to probe the diffusion one receptor 
at a time. One such approach is single particle tracking (SPT), where the receptor is 
exogenously labeled with a fluorophore and the diffusion of labeled receptor is extracted by 
following the trajectory of the label [15]. SPT has been used to study the diffusion of a 
variety of receptors such as G protein-coupled receptors, epidermal growth factor receptor, 
and homomeric α3-containing glycine receptor [16-18]. For SPT, it is imperative that the 
signal from the fluorophore be bright and photostable to facilitate fast acquisition times over 
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long durations. Inorganic quantum dots (QDs) satisfy the requirements, and the size of the 
QD can be of similar magnitude to many receptors. Labeling specificity to the desired 
receptor is achieved by modifying the QD surface with a ligand or another similar strategy 
[19]. A recent review article summarizes the use of SPT to measure receptor diffusion [20]. 
Given the importance of electrostatic interactions in RAGE binding to ligand, 
increasing the negative charge of the ligand may influence binding and the functional 
consequences of binding to RAGE; this may include influencing the lateral diffusion of 
RAGE. To test this hypothesis, MGO-BSA with different extents of primary amine 
modification are prepared. The extent of modification is characterized by measuring free 
primary amine content and zeta potentials. Ligand binding between MGO-BSA and soluble 
RAGE (sRAGE, containing the RAGE extracellular domains V, C1 and C2) is measured in 
vitro using SPR. The effect of ligand on the lateral diffusion of HA-RAGE is measured with 
single particle tracking (SPT). The role of cholesterol in ligand-induced changes to HA-
RAGE lateral diffusion is measured by depleting cellular cholesterol concentrations with 
methyl-β-cyclodextrin. Finally, ERK phosphorylation is studied in cells to identify possible 
correlations in HA-RAGE lateral diffusion, signaling, and ligand binding properties.  
 
3.3 Materials and Methods 
Cell culture, protein expression and Western blotting  
All microscopy and molecular biology experiments were performed using bovine 
artery GM07373 endothelial cells (Coriell Institute Biorepositories, Camden, NJ) maintained 
according to the procedure described previously [14]. GM07373 cells were transfected with 
purified recombinant plasmid using Lipofectamine 2000 and the manufacturer's instructions 
(Life Technology). Transfected GM07373 cells were selected using Geneticin sulfate (Santa 
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Cruz Biotechnology, Inc., Santa Cruz, CA). The transfected cells were established to express 
HA-RAGE protein stably before microscopy or molecular biology experiments. Details of 
the HA-RAGE expression plasmid, soluble RAGE expression and purification and Western 
blotting experiments are provided in the supplementary material.   
Preparation and characterization of methylglyoxal (MGO) modified-bovine serum 
albumin (BSA) 
BSA was modified with different concentrations of MGO to generate various MGO-
BSA. 10 mM, 40 mM, 60 mM, 80 mM and 100 mM MGO was incubated with 50 mg/mL 
BSA in 0.1 M phosphate buffered saline (PBS) pH 7.4 at 37 °C for five days. On the fifth 
day, unreacted MGO was removed by dialysis in 0.1 M PBS. The ortho-phthaldialdehyde 
assay was performed to evaluate the extent of modification via quantifying the free primary 
amine content of BSA [21]. The fluorescence intensity was measured with a microplate 
reader (Synergy 2 Multi-Mode Reader, BioTek) at excitation and emission wavelengths of 
340 nm and 435 nm, respectively.  The resulting fluorescence intensities were translated into 
a percent modification using the signal measured from unmodified BSA (without MGO 
incubation) as a control. 
Zeta potential measurement 
The zeta potential and protein mobility of the prepared MGO-BSA were obtained 
using a Zetasizer Nano ZS (Malvern Instruments, Ltd) with laser Doppler velocimetry. 
MGO-BSA and BSA control were diluted five times in PBS solution at pH=7.4. Three 
replicates were measured for each sample at 25 °C and 200 continuous runs.  
Surface plasmon resonance (SPR) 
The binding affinity between MGO-BSA and sRAGE was measured using a home-
built SPR instrument. The MGO-BSA was immobilized by physisorption on a 50-nm thick 
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gold film. 100 nM sRAGE in HEPES buffer (pH=7.5) was pumped into a flow cell at the 
flow rate of 0.8 ml/min for one minute, and then the SPR response was monitored for 20 min. 
After the 20 min association step, the HEPES buffer was flowed for 1 min at the flow rate of 
0.8 ml/min, and then the response during the dissociation step was monitored for an 
additional 20 min. The kinetic parameters for the MGO-BSA/sRAGE interaction were 
obtained from the resulting sensorgrams as previously reported using the equations provided 
in the supplementary material [22].  
Quantum dot conjugation and sample preparation for single particle tracking (SPT) 
Quantum dots (QDs, ThermoFisher Scientific) conjugated with streptavidin with an 
approximate diameter of 15 to 20 nm were used as a fluorescent probe in SPT experiments. 5 
µL of streptavidin coated QDs in 1 µM borate buffer were added to 21 µL of monoclonal 
HA-epitope tag antibody conjugated with biotin (ThermoFisher Scientific) in 74 µL of PBS 
buffer (pH=7.4) and incubated for 2 hours at room temperature. The resulting anti-HA 
labeled QDs (AHA-QDs) were stored in the refrigerator until use.  
Cells were sub cultured onto 8-well Nunc™ Lab-Tek™ chambered glass slide for 24 
hours. On the next day, spread cells were incubated with 3% (W/V) BSA in DMEM (BSA-
DMEM) medium overnight before imaging experiments to minimize the nonspecific binding.  
Cells were either used without further treatment or treated with specific MGO-BSA (5 
mg/mL in BSA-DMEM) for 1 h. In the case of sequential cholesterol depletion, cells were 
further treated with MβCD (5 mM in BSA-DMEM) before labeling with AHA-QDs. For 
SPT experiments, AHA-QDs were sonicated for 2 h to avoid aggregation of the QDs. The 
AHA-QDs were diluted to 100 pM in the imaging medium containing 0.1% (W/V) BSA. The 
low AHA-QD concentration reduces the possibility that two or more QDs are colocalized 
within the diffraction volume. Cells were incubated with the AHA-QDs for 15 minutes at 37 
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ºC in the incubator. Cells were then rinsed with imaging medium five times before mounting 
the sample onto the microscope.  
The SPT experiments were performed using a Nikon Eclipse TE2000U microscope 
(Melville, NY, USA) operating in wide-field, epi-fluorescence mode with a 100× objective 
and mercury lamp illumination. Filter sets for excitation (425/45 nm) and emission (605/20 
nm) were obtained from Omega Optical (XF304-1, Brattleboro, VT, USA). The microscope 
was housed inside a physiological chamber. All imaging experiments were performed at 36 ± 
2 ºC.  Fluorescence images were collected using a PhotonMAX 512 EMCCD camera 
(Princeton Instrument, Trenton, NJ, USA) with a 40 ms camera exposure time and a full-chip 
(512×512 pixels) field of view for a total of 40 s.   
QD binding specificity, localization, and tracking 
The AHA-QD binding specificity was measured using two cell lines: GM07373 cells 
that do not express HA-RAGE and GM07373 cells that express HA-RAGE. Nonspecific 
binding was reported as the average number of AHA-QDs in cells lacking HA-RAGE 
divided by the average number in cells expressing HA-RAGE. The ImageJ particle tracker 
2D/3D plug-in implementing the algorithm developed by Sbalzarini and Koumoutsakos was 
used for detecting QDs, localization, and tracking [23, 24]. The intrinsic blinking property of 
the QDs was used to identify single particles and the extracted single particle trajectories that 
were at least 8 s in duration (i.e., in between blinking events) were further analyzed.  
SPT data analysis 
Extracted single particle trajectories were analyzed using APM_GUI (Analyzing 
Particle Movement with Graphical User Interface), which is a MATLAB-implemented 
application based on an established algorithm reported by Simson and co-workers [25, 26]. 
Diffusion coefficients measured for AHA-QDs on GM07373 cells were used as a threshold 
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to select mobile trajectories to account for the non-specific binding. All mobile trajectories 
were classified either as confined or as non-confined (Brownian) trajectories based on the 
probability of particle motion being Brownian in a given region. The probability level or the 
confinement index (L) was calculated for each trajectory to highlight the regions of confined 
behavior as described previously [26]. The simulated Brownian trajectories for a range of 
diffusion coefficients were used to estimate the critical confinement index (Lc) and critical 
confinement time (tc). These two parameters were used as a threshold to separate Brownian 
motion from confined motion. In general, the greater the value of L, the greater the tendency 
for a trajectory to exhibit confined motion. For a given trajectory, a confined diffusion region 
is defined by the regions where L increases above Lc for a duration of time longer than tc. 
Based on the simulation data for Brownian trajectories, the trajectories with L > 3.16 for a 
duration tc > 1.95 s had a 99.93 % likelihood to be in confined motion. For a trajectory 
classified as confined, the size of the confinement region, the duration of the confinement 
time, and the diffusion coefficients inside the confined zones and outside the confined 
regions were further analyzed. The plot of mean square displacement (MSD) vs time was 
used to calculate the characteristic diffusion coefficient of a given region [25]. RAGE is 
reported to oligomerize on the cell surface in the presence of ligand [27-29]. It is not possible 
to know if a tracked receptor is a monomer or part of an oligomer based on its diffusion 
coefficient. This is because the diffusion coefficient has a logarithmic dependence on inverse 
radius, and is thus not particularly sensitive to clustering. 
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3.4 Results and Discussion 
Characterization of MGO-BSA ligand and its interactions with RAGE  
Five MGO-BSA samples were prepared by incubating BSA with 10 to 100 mM 
MGO. Two of the possible amino acid modifications that occur after MGO incubation are 
shown in Figure S3.1. The extent of primary amine modification as measured by the ortho-
phthaldialdehyde assay increases linearly (R2 = 0.98) when increasing concentrations of 
MGO are used for the in vitro modification of BSA (Figure 3.1A). The percent primary 
amine modification ranges from 24 to 74% compared to control BSA that is not incubated 
with MGO. BSA that has not been incubated with MGO has a net positive surface charge, 
but all MGO-BSA samples have a net negative surface charge that increases as the MGO 
concentration used for the modification of BSA increases (Figure 3.1B).  
RAGE ligands mainly bind to the extracellular V and C1 domains [9, 10], so a 
soluble variant for RAGE (sRAGE) is commonly used as an antigen for binding affinity 
studies. Surface plasmon resonance measurements of the dissociation constant (Kd) between 
each MGO-BSA sample and sRAGE are shown in Figure S3.2. The Kd values obtained from 
the SPR curves are shown in Figure 3.1C. With increasing percent primary amine 
modification, the affinity of MGO-BSA for sRAGE increases (i.e., the solution concentration 
of MGO-BSA required to occupy half of the available binding sites on sRAGE decreases). 
These affinities are of the same order of magnitude as previously reported for similar RAGE 
ligands [13]. Combining the results of the affinity and MGO-BSA surface charge 
measurements, the affinity between sRAGE and MGO-BSA is linearly dependent (R2 = 0.94) 
on the net MGO-BSA negative surface charge, which is consistent with an interaction to a 
positively charged binding pocket on the V-domain of sRAGE.  
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Extracellular HA epitope tag enables the specific labeling of QDs to RAGE  
Single particle tracking experiments require the specific binding between a 
nanoparticle and a receptor. In these studies the nanoparticles are fluorescent quantum dots 
(QDs). A ligand can be directly coated on the surface of the QDs [30, 31], however, up to 
88% nonspecific binding is observed when ligand (AGE or S100A8/A9)-coated QDs are 
incubated with cells that do not express RAGE (data not shown). A possible reason for the 
observed nonspecific binding may be due to the affinity of RAGE ligands for other 
membrane proteins [8]. As an alternative specific labeling route, the 9 amino acid 
(YPYDVPDYA) hemagglutinin (HA) tag was added to the RAGE extracellular domain at a 
position three amino acids away from the N-terminus of the signal peptide. The cellular 
signaling in HA-RAGE is similar to RAGE lacking the HA tag as measured by 
phosphorylation of ERK (p-ERK). There is a two-fold increase in p-ERK in GM07373 cells 
expressing HA-RAGE compared to GM07373 cells that do not express detectable amounts of 
RAGE (Figure S3.3). This increase is consistent with the two-fold increase in p-ERK in 
GM07373 cells expressing RAGE lacking the HA tag, as reported previously [14]. In 
addition, a control experiment showed no change in p-ERK when HA-RAGE expressing 
cells were first exposed to HA antibody, to check for a blocked ligand binding site, followed 
by incubation with MGO-BSA with 41% primary amine modification (Figure S3.4). 
Anti-HA-coated QDs (AHA-QDs) are generated by incubating streptavidin-coated 
QDs with biotin-labeled anti-HA to specifically label HA-RAGE. The specific binding of 
AHA-QDs for HA-RAGE is measured using cells that are incubated with 100 pM AHA-QDs 
as shown in Figure S3.5. The number of AHA-QDs per cell is counted for at least 34 cells 
expressing HA-RAGE or lacking HA-RAGE. There is 4.8% nonspecific AHA-QD binding, 
indicating that a majority of the AHA-QDs observed in the HA-RAGE expressing cells are 
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specifically bound to HA-RAGE. A goal of this work is to measure the diffusion properties 
of HA-RAGE as measured by the trajectories of AHA-QDs. The nonspecifically bound 
AHA-QDs on the cell membrane are immobile and do not diffuse. To prevent biasing the 
HA-RAGE diffusion measurements, the immobile AHA-QDs are excluded from the analysis 
since immobile trajectories could arise from either nonspecific binding or immobile HA-
RAGE. Excluding the immobile AHA-QDs from the analysis does prohibit measuring the 
fraction of immobile HA-RAGE.  
Diffusion properties for the Brownian trajectories of HA-RAGE in the presence and 
absence of MGO-BSA ligand 
Fluorescence microscopy is used to collect at least 400 trajectories of AHA-QDs from 
at least 10 cells to measure the diffusion of HA-RAGE in the presence or absence of MGO-
BSA. Trajectories are classified as exhibiting either Brownian or confined diffusion. If the 
trajectory has a minimum of one confined domain (where the confinement index (L) is higher 
than the critical confinement value for longer than the critical time as described in the 
experimental section) then the trajectory is classified as confined. In the absence of ligand, 
31% of HA-RAGE exhibit Brownian diffusion and 69% exhibit confined diffusion, 
indicating a majority of HA-RAGE measured by SPT exhibit confined diffusion at least once 
in ~20 seconds (i.e., the average length of a trajectory as shown in Table 3.1). When the cells 
are incubated with MGO-BSA, a 3 to 7% increase in the Brownian population is measured 
when the MGO-BSA percent primary amine modification is at least 41%. 
The average diffusion coefficient for the Brownian trajectories of HA-RAGE in the 
absence of ligand is 0.085 µm2/s. The histogram of diffusion coefficients (Figure 3.2) shows 
a bimodal population with maximum diffusion coefficients of 0.0006 and 0.065 µm2/s. When 
the cells are exposed to 24% MGO-BSA, the average diffusion coefficient drops to 0.039 
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µm2/s (Table 3.1). The distribution of diffusion coefficients remains bimodal but with a 
higher percentage of the slower population (Figure 3.2). Between 24% MGO-BSA and 62% 
MGO-BSA treatment, there is an increase in the average diffusion coefficient and a decrease 
in the population of HA-RAGE in the slower diffusion coefficient range. Interestingly, 
compared to the 62% MGO-BSA treatments, the average diffusion coefficient decreases after 
74% MGO-BSA treatment, and there is a recurrence of the bimodal diffusion coefficient 
distribution. With increasing percent primary amine modification, the viscosity of the ligand 
solution increases, which is indicative of protein cross linking. It is possible that the decrease 
in the diffusion coefficient in going from the 62% to the 74% MGO-BSA sample is a result 
of extensive protein cross linking. The in vitro sRAGE binding studies (i.e., the SPR studies) 
may be less sensitive to the degree of protein cross linking, possibly because the sRAGE is 
immobilized in a range of orientations on the sensor surface that may have different binding 
capacities, while RAGE in the membrane is expected to have fewer degrees of freedom. Thus 
the affinity measured by SPR may not be representative of the binding affinity of full length 
RAGE in the cell membrane if extensive protein cross linking is present. It is also possible 
that ligand binding to another receptor (as stated above AGE binds to other receptors) may 
indirectly impact RAGE diffusion.  
Diffusion properties for the fraction of HA-RAGE with at least one confined domain in 
the presence and absence of MGO-BSA ligand 
Two regions are identified for each trajectory classified as exhibiting a confined 
domain based on the measured confinement index (L). First, regions inside the confined 
regions where L is higher than the critical confinement value for longer than the critical time. 
Second, since the time HA-RAGE is in confined domains (Table 3.2) is less than the average 
trajectory time, parts of the trajectory represent diffusion outside confined domains.  
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Outside of the confined domains, Brownian diffusion properties are expected. Table 
3.2 and Figure 3.3 confirm that the diffusion coefficients measured outside the confined 
domains of diffusion are within expected experimental uncertainties to the values measured 
for the trajectories exhibiting pure Brownian diffusion shown in Table 3.1 and Figure 3.2, 
including a maximum average diffusion coefficient (0.085 µm2/s) measured after treatment 
with 62% MGO-BSA. When HA-RAGE is in a confined domain and in the absence of 
ligand, the average diffusion coefficient is 7-fold slower compared to HA-RAGE exhibiting 
Brownian diffusion. For HA-RAGE in confined domains in the presence of MGO-BSA, the 
same trends are measured in the average diffusion coefficient and the histogram of diffusion 
coefficients as measured for HA-RAGE exhibiting Brownian diffusion, although the 
magnitude of the average diffusion coefficient is 4 to 6-fold slower within the confined 
domains (Table 3.2 and Figure 3.4). 
The average confinement radius and time in confined domains measured for HA-
RAGE in the absence of ligand were 0.199 µm and 3.89 seconds, respectively (Table 3.2). 
The confinement radius decreases after treatment with 24% MGO-BSA, and the confinement 
radius is the largest after 62% MGO-BSA treatment (Figure 3.5, Table 3.2).  
Overall the confinement radius shows the same trend as the average diffusion 
coefficient with increasing MGO-BSA percent primary amine modification. The time HA-
RAGE remains in confined domains remains approximately 4 seconds after cellular 
incubation with MGO-BSA. While the size of the domains of confined diffusion varies with 
MGO-BSA incubation, the time HA-RAGE spends within these domains is relatively 
independent of ligand incubation. 
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p-ERK and HA-RAGE expression are independent of the percent primary amine 
modification on MGO-BSA 
Phosphorylation of ERK (p-ERK) and Akt (p-Akt) have been used to measure RAGE 
signaling [14, 29]. After incubation with MGO-BSA, there is a 2 to 2.4-fold increase in p-
ERK compared to p-ERK measured in the absence of MGO-BSA (Figure 3.6A and 3.6B). 
There is no statistically significant difference in p-ERK phosphorylation for cells incubated 
with varying MGO-BSA percent primary amine modifications. A similar trend was measured 
for cells lacking HA-RAGE expression (Figure S3.3). Given the similar response in cells that 
express HA-RAGE and cells lacking HA-RAGE expression, it is possible that a non-RAGE-
dependent mechanism is responsible for some or all of the increase in p-ERK  after 
incubation with MGO-BSA. While it cannot be concluded that MGO-BSA incubation results 
in a RAGE-dependent increase in p-ERK, the experimental design ensures the changes in the 
diffusion properties discussed above are specific to RAGE, whether or not they are the result 
of a direct interaction between MGO-BSA and RAGE or an indirect interaction with other 
membrane components. In contrast to the increasing p-ERK phosphorylation after MGO-
BSA incubation, no statistically significant difference in p-Akt is measured is cells 
expressing or lacking HA-RAGE (Figure S3.6). 
There is a 15 to 28% decrease in HA-RAGE expression after incubating cells with 
MGO-BSA (Figure 3.6C and 3.6D). As with p-ERK, the reduced HA-RAGE expression is 
statistically the same regardless of the percent primary amine modification on MGO-BSA. 
Previously, RAGE expression was shown to be down regulated in monocytes upon 
incubation with AGE prepared by glyceraldehyde modification [32]. The glyceraldehyde-
prepared AGE reported in this previous study best matches the AGE used in the studies 
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reported herein. In some experimental conditions, RAGE expression has been shown to be 
upregulated by incubation with ligand [33, 34].  
Insight into the nature of the confined domains of diffusion: Cholesterol depletion 
eliminates the ligand-induced changes to HA-RAGE diffusion 
Previously RAGE has been reported to be part of cholesterol rich membrane domains 
[35, 36]. However, cholesterol depletion did not affect the lateral diffusion properties of 
RAGE as observed with FRAP [14]. As measured by SPT, HA-RAGE diffusion is 2 to 4× 
slower for Brownian and confined diffusion when cholesterol is extracted from the cell 
membrane (Table 3, 4). In addition the radius of confined diffusion decreases from 0.199 μm 
to 0.160 μm after cholesterol extraction. These changes are similar to the changes measured 
after 24% MGO-BSA incubation (Table 3.1, 3.2). 
The effect of cholesterol depletion on ligand-induced changes in HA-RAGE lateral 
diffusion is explored by depleting cholesterol from untreated and 62% MGO-BSA-treated 
cells. Considering all diffusion properties for Brownian and confined diffusion, the changes 
in HA-RAGE diffusion that are measured after 62% MGO-BSA treatment are not measured 
when cholesterol is extracted from the membrane (Table 3.3, 3.4 and Figure S3.7, S3.8, S3.9 
and S3.10). After treatment with 62% MGO-BSA and cholesterol extraction, the HA-RAGE 
diffusion parameters are similar to the values measured after cholesterol extraction without 
ligand incubation. The 62% MGO-BSA-induced changes in HA-RAGE diffusion are 
cholesterol dependent, and are not measured when cholesterol concentrations and/or 
cholesterol-dependent structures in the membrane are altered. It is possible that the effect of 
cholesterol depletion on RAGE diffusion is dependent upon the level of primary amine 
modifications, and is worthy of further study. 
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3.5 Conclusions 
MGO-BSA binding affinity to sRAGE was observed to be dependent on the percent 
primary amine modification and the net negative surface charge on the ligand. MGO-BSA 
incubation affected HA-RAGE lateral diffusion, however, there was no direct correlation 
measured between ligand binding affinity, net negative surface charge on the ligand and HA-
RAGE diffusion coefficient, radius of confinement or duration of confinement. This may be 
the result of increasing levels of protein cross linking with increasing primary amine 
modification. Cholesterol depletion was found to ameliorate the 62% MGO-BSA ligand 
induced changes on HA-RAGE lateral diffusion, indicating a direct or indirect role for 
cholesterol in MGO-BSA-induced changes to HA-RAGE diffusion. Other factors such as 
ligand valancy and receptor clustering, as well as, other membrane changes that may result 
from the MGO-BSA ligand are possible avenues for further study.  
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3.7 Figures and Tables 
 
Figure 3.1. Characterization of methylglyoxal modified-bovine serum albumin (MGO-BSA). 
(A) Percent modification of free primary amines in BSA as measured by an ortho-
phthaldialdehyde assay after modification with the indicated concentration of MGO; (B) 
Measured Zeta potential for MGO-BSA with the indicated percent primary amine 
modification; (C) Dissociation constant as measured by SPR for MGO-BSA with the 
indicated percent primary amine modification and sRAGE.  
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Figure 3.2. Histograms of diffusion coefficients for the Brownian trajectories of HA-RAGE 
in the GM07373 cell membrane treated with MGO-BSA having the indicated percent 
primary amine modification. The diffusion coefficient is plotted as the negative natural 
logarithm; slower diffusion coefficients appear on the right side of the graph. The dotted line 
is shown for clarity in comparing the changes in the distribution.  
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Figure 3.3. Histograms of diffusion coefficients for the confined trajectories (outside 
domains of confined diffusion) of HA-RAGE in the GM07373 cell membrane treated with 
MGO-BSA having the indicated percent primary amine modification. The diffusion 
coefficient is plotted as the negative natural logarithm. The dotted line is shown for clarity in 
comparing the changes in the distribution. 
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Figure 3.4. Histograms of diffusion coefficients for the confined trajectories (inside domains 
of confined diffusion) of HA-RAGE in GM07373 cell membrane treated with MGO-BSA 
having the indicated percent primary amine modification. The diffusion coefficient is plotted 
as the negative natural logarithm. The dotted line is shown for clarity in comparing the 
changes in the distribution.  
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Figure 3.5. Distribution of confinement radius for the confined trajectories (inside domains 
of confined diffusion) of HA-RAGE in the GM07373 cell membrane treated with MGO-BSA 
having the indicated percent primary amine modification. The corresponding fits (red solid 
line) are obtained by fitting the distribution to a log-normal function.  
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Figure 3.6. Western blot analysis of phosphorylation of ERK (p-ERK) and HA-RAGE 
expression in the GM07373 cell lysate with: (Lane 1) no treatment, or 5 mg/mL MGO-BSA 
treatment with the following percent primary amine modification: (Lane 2) 24%, (Lane 3) 
41%, (Lane 4) 57%, (Lane 5) 62%, or (Lane 6) 74%. Fluorescence images of the PVDF 
membrane probed with: (A) p-ERK antibody or vinculin antibody, and (C) RAGE antibody 
or vinculin antibody. Average (n = 5) fluorescence intensities of the: (B) 42 kDa band of p-
ERK divided by the vinculin band and (D) RAGE band divided by the vinculin band. 
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Table 3.1. Average diffusion parameters for the Brownian trajectories of HA-RAGE in the 
GM07373 cell membrane treated with MGO-BSA with the indicated percent primary amine 
modification.  
 % of Brownian 
trajectories 
D (µm2/s) Average length of the trajectory 
(s) 
No treatment 31% 0.085 20 ± 10 
24% MGO-BSA 
treatment 
31% 0.039 
(p < 0.01) 
19 ± 9 
41% MGO-BSA 
treatment 
36% 0.052 
(p < 0.01) 
19 ± 9 
57% MGO-BSA 
treatment 
34% 0.069 
(p < 0.01) 
20 ± 10 
62% MGO-BSA 
treatment 
39% 0.115 
(p < 0.01) 
20 ± 9 
74% MGO-BSA 
treatment 
36% 0.050 
(p < 0.01) 
30 ± 10 
Diffusion coefficients with a p-value below 0.05 are highlighted in bold to show statistically 
significant differences compared to the cells that were not treated. The percentage of 
Brownian trajectories is obtained from counting, so no uncertainty is provided. 
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Table 3.2. Average diffusion parameters for the confined trajectories of HA-RAGE in the 
GM07373 cell membrane treated with MGO-BSA with the indicated percent primary amine 
modification.  
 D (µm2/s) 
(Outside 
confined 
domains) 
D (µm2/s) 
(Inside 
confined 
domains) 
Radius 
(µm) 
Confinement 
time (s) 
Average 
length of the 
trajectory (s) 
No treatment 0.060 0.012 0.199 3.89 32 ± 9 
24% MGO-BSA 
treatment 
0.031 
(p < 0.01) 
0.007 
(p < 0.01) 
0.138 
(p < 0.01) 
4.09 
(p < 0.01) 
31 ± 9 
41% MGO-BSA 
treatment 
0.050 
(p < 0.01) 
0.013 
(p=0.09) 
0.192 
(p < 0.01) 
3.90 
(p=0.07) 
30 ± 10 
57% MGO-BSA 
treatment 
0.053 
(p < 0.01) 
0.011 
(p=0.09) 
0.195 
(p=0.06) 
3.99 
(p=0.2) 
30 ± 10 
62% MGO-BSA 
treatment 
0.085 
(p < 0.01) 
0.026 
(p < 0.01) 
0.294 
(p < 0.01) 
3.46 
(p=0.19) 
31 ± 9 
74% MGO-BSA 
treatment 
0.042 
(p < 0.01) 
0.010 
(p=0.01) 
0.178 
(p=0.02) 
3.97 
(p < 0.01) 
20 ± 10 
Entries with a p-value below 0.05 are highlighted in bold to show statistically significant 
differences compared to the cells that were not treated.   
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Table 3.3. Average diffusion parameters for the Brownian trajectories for HA-RAGE in the 
GM07373 cell membrane for the indicated cellular treatments. 
 % of 
Brownian 
trajectories 
D (µm2/s) Average length of the 
trajectory (s) 
No treatment 31% 0.085 20 ± 10 
62% MGO-BSA ligand 36% 0.115 
(p < 0.01) 
20 ± 9 
5 mM MβCD to extract 
cholesterol 
 
33% 0.036 
(p < 0.01) 
19 ± 9 
62% MGO-BSA and 5mM 
MβCD 
 
34% 0.041 
(p < 0.01) 
18 ± 9 
Diffusion coefficients with a p-value below 0.05 are highlighted in bold to show statistically 
significant differences compared to the cells that were not treated. The percentage of 
Brownian trajectories is obtained from counting, so no uncertainty is provided. 
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Table 3.4. Average diffusion parameters for the confined trajectories for HA-RAGE in the 
GM07373 cell membrane for the indicated cellular treatments. 
 D (µm2/s) 
(Outside 
confined 
domains) 
D (µm2/s) 
(Inside 
confined 
domains) 
Radius 
(µm) 
Confinement 
time (s) 
Average 
length of the 
trajectory 
(s) 
No treatment 0.06 0.012 0.199 3.89 32 ± 9 
62% MGO-
BSA ligand 
0.085 
(p < 0.01) 
0.026 
(p < 0.01) 
0.294 
(p < 0.01) 
3.46 
(p=0.19) 
31 ± 9 
5 mM MβCD 
to extract 
cholesterol 
 
0.035 
(p < 0.01) 
0.003 
(p < 0.01) 
0.160 
(p < 0.01) 
3.94 
(p=0.55) 
30 ± 10 
62% MGO-
BSA and 
5mM MβCD 
 
0.038 
(p < 0.01) 
0.008 
(p < 0.01) 
0.164 
(p < 0.01) 
3.92 
(p=0.33) 
30 ± 10 
Entries with a p-value below 0.05 are highlighted in bold to show statistically significant 
differences compared to the cells that were not treated. 
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3.8 Supporting Information 
HA-RAGE plasmid, expression and purification 
Full-length human RAGE coding pcDNA3 vector (pcDNA3.RAGE) was a generous 
gift from Prof. Ann Marie Schmidt (New York School of Medicine) [1]. All oligonucleotides 
for generating recombinant proteins were obtained from Integrated DNA Technologies 
(Coralville, IA). The DNA sequence coding for human influenza hemagglutinin (HA) tag 
(YPYDVPDYA) was inserted in the N-terminal of RAGE plasmid using the following 
oligonucleotides 5’-
TACCCGTACGACGTGCCGGACTACGCCATCACAGCCCGGATTGGC-3’ and 5’-
GGCGTAGTCCGGCACGTCGTAGTTTTGAGCACCTACTACTGCCC-3’ to generate 
pcDNA3.HA-RAGE plasmid as reported previously [2].  The recombinant plasmid was first 
transformed into DH5α E. Coli cells for expression and purification and transformed cells 
were selected on Luria broth agar (US biological, Salem, MA) plates containing 50 µg/mL 
Carbenicillin (Sigma-Aldrich, St. Louis, MO).  
Expression and purification of soluble RAGE 
Soluble RAGE (sRAGE) is an endogenous splice variant of full length RAGE lacking 
the transmembrane and intracellular domains. His-tagged sRAGE transformed E. Coli strain 
Origami™ B (DE3) was a generous gift from Dr. Walter Chazin (Vanderbilt University). The 
cells were grown at 37 °C until the optical density at 600 nm was approximately 0.8 AU. 
Then sRAGE’s expression was induced with 0.5 mM isopropyl β-D-1-thiogalactopyranoside. 
After 6 hours at room temperature, cells were harvested and the resulting cell pellet was 
resuspended in buffer A (20mM Tris-HCL, 300 mM NaCl, 20 mM imidazole at pH 8.0) with 
5 mg/mL lysozyme. His-tagged sRAGE from the cell lysate was purified with nickel 
nitrilotriacetic acid (Ni-NTA) agarose beads (Qiagen) using the manufacturer’s instructions. 
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The Ni-NTA column was washed with buffer A, and elution fractions were collected in 
buffer B (20 mM Tris-HCL, 300 mM NaCl, 150 mM imidazole at pH 8.0). The fractions 
containing sRAGE were dialyzed with HEPES buffer (15 mM HEPES, 150 mM NaCl at pH 
7.5) for 24 hours. Finally, the sRAGE’s concentration was quantified with the bicinchoninic 
acid assay.  
Kinetic equations for interaction between MGO-BSA and sRAGE in SPR experiment 
Taking into account the mass transfer in the flow channel, the interaction can be 
described by following shceme. The sensorgrams (Figure S3.2) were fitted by following 
equations. 
  
HIJKL
H = MNOIJL1IKL − MN00IJKL 
HIJL1H = MPQIJLRSTU − MPQIJL1 − MNOIJL1IKL + MN00IJKL 
HIJLRSTUH = −(MPQIJLRSTU − MPQIJL1) 
Where [A]bulk is the solution concentration of sRAGE flowed into the flow cell. [A]s is the 
concentration of sRAGE due to the mass transfer near to the surface. [B] is the concentration 
of MGO-BSA. ktr is the mass transfer rate constant. kon and koff are the association and 
dissociation rate constant, respectively. The dissociation constant is defined as Kd = koff /kon.  
Western blot analysis 
GM07373 or HA-RAGE expressing GM07373 cells were sub-cultured in 25 cm2 
culture flasks for 24 hours. On the following day, cells were incubated in 3% BSA in DMEM 
media overnight. Cells were either used without further treatment or treated with specific 5 
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mg/mL MGO modified-BSA (MGO-BSA) in DMEM with 3% (w/v) BSA for 1 hour. For 
sequential cholesterol depletion, cells were further incubated with 5 mM MβCD in in DMEM 
with 3% (w/v) BSA for 30 minutes. Cells were rinsed with phosphate buffered saline (PBS) 
prior to cell lysis.  Cell lysis was performed with 300 µL of cold RIPA buffer (150 mM 
sodium chloride, 1.0% NP-40 detergent, 0.5% sodium deoxycholate, 0.1%  SDS, 50 mM 
Tris, pH 8.0) with HaltTM protease inhibitor cocktail (1×, Thermo Scientific, Rockford, IL). 
After the initial lysis treatment, cells were passed through a 21 gauge needle to ensure 
complete cell lysis. The protein mixture (20 µL of the sample, 7 µL of gel loading buffer and 
3 µL of sample reducing agent) was first separated on a NuPAGE® Novex® 4-12% Bis-Tris 
protein gel (Life Technology, Eugene, OR) and then electro blotted onto Immun-Blot® LF 
PVDF membrane (Bio-Rad, Hercules, CA) as described previously [3, 4]. The primary 
antibodies used for probing the PVDF membrane were: anti-RAGE rabbit (H-300, Santa 
Cruz Biotechnology), anti-vinculin goat (sc-7649, Santa Cruz Biotechnology), anti-p-ERK 
rabbit (Tyr 204, sc-101761, Santa Cruz Biotechnology), anti-p-Akt rabbit (Ser 473, sc-
101761, Santa Cruz Biotechnology). Fluorescence from the labeled secondary antibody was 
measured on a Typhoon FLA 9500 variable mode laser scanner (GE Healthcare, Waukesha, 
WI). The vinculin protein band was used as a loading control in all Western blot 
experiments. The resulting fluorescence band intensities were quantified with ImageJ. 
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Figures and tables for supporting information for Chapter 3 
 
 
 
Figure S3.1. Two of the chemical modifications on lysine and arginine residues after 
incubation with methylglyoxal. A more complete list of protein modifications that can occur 
after incubation with methylglyoxal can be found in a review by Vistoli et al  [5]. 
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Figure S3.2. Measured surface plasmon resonance (SPR) response over time for binding 
between MGO-BSA with the indicated percent primary amine modification and sRAGE. The 
corresponding fits to equations 1 to 3 are shown as solid black lines.   
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Figure S3.3. Western blot analysis of the GM07373 cell lysate (no detectable RAGE 
expression) with: (Lane 1) no treatment, or 5 mg/mL MGO-BSA treatment with the 
following percent primary amine modification: (Lane 2) 24%, (Lane 3) 41%, (Lane 4) 57%, 
(Lane 5) 62%, or (Lane 6) 74%. (Lane 7) No treatment HA-RAGE expressing GM07373 cell 
lysate shows higher p-ERK intensities compared to cells that do not express RAGE (Lane 1). 
(A) Fluorescence images of the PVDF membrane probed with p-ERK antibody or vinculin 
antibody. (B) Average (n = 5) normalized fluorescence intensities of the 42 kDa band of p-
ERK divided by the vinculin band. 
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Figure S3.4. Western blot analysis of phosphorylation of ERK (p-ERK) in the HA-RAGE 
expression GM07373 cell lysate with: (Lane 1) no treatment, (Lane 2) HA antibody 
treatment, (Lane 3) 5 mg/mL MGO-BSA treatment with 41% primary amine modification, 
(Lane 4) HA antibody treatment prior to 5 mg/mL MGO-BSA treatment with 41% primary 
amine modification.  
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Figure S3.5. Representative fluorescence images after incubation of 100 pM AHA-QDs (in 
0.1 % w/v BSA-imaging medium for 15 minutes at 37 ºC) with:  (A) GM07373 and (B) HA-
RAGE expressing GM07373 cells. The cell boundaries are outlined in white. The scale bar in 
the lower left corner of the image B is the same for both images: 20 µm.  
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Figure S3.6. Western blot analysis of the (A, B) HA-RAGE expressing GM07373 or (C, D) 
GM07373 cell lysate with: (Lane 1) no treatment, or 5 mg/mL MGO-BSA treatment with the 
following percent primary amine modification: (Lane 2) 24%, (Lane 3) 41%, (Lane 4) 57%, 
(Lane 5) 62%, or (Lane 6) 74%. (A, C) Fluorescence images of the PVDF membrane probed 
with p-Akt antibody or vinculin antibody. (B, D) Average (n = 5) normalized fluorescence 
intensities of the 42 kDa band of p-Akt divided by the vinculin band.   
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Figure S3.7. Histograms of diffusion coefficients for the Brownian trajectories of HA-RAGE 
in the GM07373 cell membrane treated with: (A) No treatment; (B) 5 mM MβCD to extract 
cholesterol from the membrane; (C) 62% MGO-BSA and (D) 62% MGO-BSA and 5 mM 
MβCD. The diffusion coefficient is plotted as the negative natural logarithm; slower 
diffusion coefficients appear on the right side of the graph. The dotted line is shown for 
clarity in comparing the changes in the distribution. 
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Figure S3.8. Distribution of confinement radius for the confined trajectories (inside domains 
of confined diffusion) of HA-RAGE in the GM07373 cell membrane treated with: (A) No 
treatment; (B) 5 mM MβCD to extract cholesterol from the membrane; (C) 62% MGO-BSA 
and (D) 62% MGO-BSA and 5 mM MβCD. The corresponding fits (red solid line) are 
obtained by fitting the distribution to a log-normal function. 
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Figure S3.9. Histograms of diffusion coefficients for the confined trajectories (inside 
domains of confined diffusion) of HA-RAGE in the GM07373 cell membrane treated with: 
(A) No treatment; (B) 5 mM MβCD to extract cholesterol from the membrane; (C) 62% 
MGO-BSA and (D) 62% MGO-BSA and 5 mM MβCD. The diffusion coefficient is plotted 
as the negative natural logarithm. The dotted line is shown for clarity in comparing the 
changes in the distribution. 
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Figure S3.10. Histograms of diffusion coefficients for the confined trajectories (outside 
domains of confined diffusion) of HA-RAGE in the GM07373 cell membrane treated with: 
(A) No treatment; (B) 5 mM MβCD to extract cholesterol from the membrane; (C) 62% 
MGO-BSA and (D) 62% MGO-BSA and 5 mM MβCD. The diffusion coefficient is plotted 
as the negative natural logarithm. The dotted line is shown for clarity in comparing the 
changes in the distribution. 
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4.1 Abstract 
Membrane diffusion is one of the key mechanisms in the cellular function of 
receptors. The signaling of receptor for advanced glycation end-products (RAGE) has been 
extensively studied in the context of several pathological conditions, however, very little is 
known about RAGE diffusion. To fill this gap, RAGE lateral diffusion is probed in native, 
cholesterol depleted and cytoskeleton altered cellular conditions. In native GM07373 cellular 
conditions, RAGE has a 90% mobile fraction and an average diffusion coefficient of 0.3 
μm2/s. When depolymerization of the actin cytoskeleton is inhibited with the small molecule 
Jasplakinolide (Jsp), the RAGE mobile fraction and diffusion coefficient decrease by 22% 
and 37%, respectively. In contrast, depolymerizing the filamentous actin cytoskeleton using 
the small molecule cytochalasin D (CD) does not alter the RAGE diffusion properties. There 
is a 70% and 50% decrease in phosphorylation of extracellular signal-regulated kinase (p-
ERK) when the actin cytoskeleton is disrupted by CD or Jsp in RAGE expressing GM07373 
cells. Disrupting the actin cytoskeleton in GM07373 cells that do not express detectable 
amounts of RAGE results in no change in p-ERK. Cholesterol depletion results in no 
statistically significant change in the diffusion properties of RAGE or p-ERK. This work 
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presents a strong link between the actin cytoskeleton and RAGE diffusion and downstream 
signaling, and serves to further our understanding of the factors influencing RAGE lateral 
diffusion. 
 
4.2 Introduction 
Lateral diffusion of membrane proteins is often interrelated with their cellular 
signaling and functions in the cell membrane [1-3]. The receptor for advanced glycation 
endproducts (RAGE) is a transmembrane protein that belongs to the immunoglobulin (Ig) 
superfamily. Many RAGE ligands have been identified, including advanced glycation 
endproducts (AGEs), S100 proteins, high mobility group box 1 (HMGB1), and amyloid-β 
fibrils [4-8]. RAGE and its signaling are associated with many disease states, including some 
types of cancer, retinal disease, cardiovascular disease, Alzheimer’s disease, respiratory 
disorders, chronic inflammation and diabetic complications [9-15]. RAGE is reported to 
activate various signaling cascades, including mitogen-activated protein kinases (MAPKs), 
Rac/Cdc42 and Janus kinases (JAK)/signal transducers and activators of transcription 
(STATs) and NF-κB [16-21]. Through these signaling pathways, RAGE influences cell 
survival, motility and the inflammatory response. Even though RAGE signaling has been 
studied extensively in different disease states, very little is reported regarding RAGE 
diffusion in the cell membrane. The goal of the current study is to investigate the lateral 
diffusion and cellular signaling of RAGE in the endothelial cell membrane and to study the 
effects of cholesterol depletion and alterations to the actin cytoskeleton on these properties. 
Cholesterol and the actin cytoskeleton play an important role in the organization of 
the cell membrane. Functional domains in the cell membrane, known as lipid rafts or lipid 
nanodomains, contain about 3 to 5-fold excess cholesterol compared to neighboring regions 
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of bilayer [22-25]. These functional domains act as platforms for localizing and signaling of 
many membrane proteins. Altering membrane cholesterol levels has been reported to affect 
the organization and signaling of a number of receptors [22, 26-30]. The actin cytoskeleton 
serves as a structural element that can affect the functionality of membrane proteins, 
including their oligomerization and transmembrane signaling [31].  
Both cholesterol and the actin cytoskeleton have been reported to play a key role in 
RAGE functions. For example Reddy et al. showed cholesterol depletion inhibited the S100-
induced effects involving RAGE in vascular smooth muscle cells and that intact caveolae are 
necessary for RAGE signaling [32]. RAGE has also been reported to be part of functional 
cholesterol-enriched domains in neural endothelial cells [33, 34]. Xiong et al. showed that 
the actin cytoskeleton played a pivotal role in RAGE-mediated plasma membrane plasticity 
in a human umbilical vein endothelial cell line [35]. They found that RAGE over expression 
reorganizes filamentous actin (F-actin) by increasing β-catenin levels, resulting in inhibition 
of membrane sealing. Although it is evident that cholesterol and the actin cytoskeleton affect 
some RAGE functions, possible roles in affecting RAGE lateral diffusion remain unknown.  
In this study, we have genetically fused monomeric red fluorescent protein (mRFP) to 
the C-terminus of RAGE and measured its lateral diffusion using fluorescence recovery after 
photobleaching (FRAP) in GM07373 endothelial cells. In FRAP, a small area on the cell 
membrane is photobleached with a focused laser beam and the fluorescence recovery from 
the diffusion of neighboring fluorescent molecules into the photobleached spot is recorded 
over time. Several models have been constructed to extract diffusion parameters such as the 
immobile population, diffusion coefficient and time-dependency of the diffusion [36, 37]. 
RAGE diffusion at native, cholesterol depleted and altered actin cytoskeleton conditions have 
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been studied. Methyl-β-cyclodextrin (MβCD) was used to deplete cellular cholesterol. The 
actin cytoskeleton was altered using cytoskeletal drugs cytochalasin D (CD) and 
Jasplakinolide (Jsp). Finally, signaling was measured by quantifying the phosphorylation of 
extracellular-signal-regulated kinase (p-ERK) at native and altered cellular conditions.  
 
4.3 Materials and Methods 
Cell culture  
All experiments were performed using bovine artery GM07373 endothelial cells 
(Coriell Institute Biorepositories, Camden, NJ). GM07373 cells were grown in complete 
growth medium consisting of Dulbecco’s modified Eagle’s medium (DMEM) (Sigma-
Aldrich, St. Louis, MO), 10% fetal bovine serum (FBS) (Irvine Scientific, Santa Ana, CA) 
and 12.5 mM Streptomycin and 36.5 mM Penicillin (Fisher Scientific, Pittsburgh, PA) in a 
water-jacketed CO2 incubator (Thermo Scientific, Waltham, MA).  Cells were sub-cultured 
using 0.25% (w/v) trypsin-EDTA (Life Technology, Carlsbad, CA) solution every two days.  
All transfected GM07373 cells were established to express respective recombinant proteins 
stably before any microscopy or molecular biology experiments were performed. Plasmid 
and transfection details are in the supplementary information. 
Western blotting  
GM07373 cells expressing RAGE (GM07373-RAGE) or RAGE-mRFP (GM07373-
RAGE-mRFP) were cultured to 100% confluence and rinsed with ice cold phosphate 
buffered saline (PBS). Cells were lysed with RIPA buffer (150 mM sodium chloride, 1.0% 
NP-40 detergent, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris, pH 8.0) with HaltTM 
protease inhibitor cocktail (1×, Thermo Scientific, Rockford, IL). After the initial lysis 
treatment, cells were passed through a 21 gauge needle to ensure complete cell lysis. The 
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protein mixture was first separated on the NuPAGE® Novex® 4-12% Bis-Tris protein gel 
(Life Technology, Eugene, OR) and then electro blotted onto Immun-Blot® LF PVDF 
membrane (Bio-Rad, Hercules, CA) as described previously [38, 39]. The PVDF membrane 
was probed following the manufacturer’s protocol (Bio-Rad). Antibodies used for probing 
were: anti-RAGE rabbit (H-300, Santa Cruz Biotechnology), anti-RFP rabbit (Life 
Technology), anti-Vinculin goat (sc-7649, Santa Cruz Biotechnology), anti-Actin rabbit (sc-
1616-R, Santa Cruz Biotechnology), anti-p-ERK rabbit (Tyr 204, sc-101761, Santa Cruz 
Biotechnology), anti-total-ERK 1/2 mouse (sc-514302, Santa Cruz Biotechnology). The 
labeled secondary antibodies were Alexa Fluor 647 goat anti-rabbit (Life technologies), 
Alexa Fluor 488 donkey anti-goat (Life technologies), Alexa Fluor 488 goat anti-mouse (Life 
technologies). Fluorescence was measured on a Typhoon FLA 9500 variable mode laser 
scanner (GE Healthcare, Waukesha, WI). The total-ERK and vinculin protein bands were 
used as a loading control in Western blot experiments. The fluorescence intensities were 
calculated from the 42 kDa band of p-ERK divided by the 42 kDa band of total-ERK or the 
42 kDa band of actin divided by the 130 kDa band of vinculin. The 42 kDa band of ERK was 
used since it has a stronger intensity than the 44 kDa ERK band. All experiments were 
performed in triplicate unless otherwise noted in figure legends. Reported p values were 
calculated using the Student’s t-test with a two-tailed homoscedastic distribution. Protein 
sequences were analyzed by mass spectrometry as reported in the supplemental information. 
FRAP sample preparation 
Sterile glass bottom culture dishes were made by attaching a cover glass (22mm × 
22mm, No. 1.5, Corning Inc., Corning, NY) to the bottom of a polystyrene petri dish (35mm 
× 10mm, Fisher Scinetific) containing a pre-drilled 3/4 inch diameter hole as described 
previously [40]. GM07373-RAGE or GM07373-RAGE-mRFP cells were sub-cultured onto 
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the culture dishes two days before the experiment.  Cells were either used without further 
treatment or treated at 37 ºC with MβCD (Sigma-Aldrich, 5mM, in serum free DMEM for 30 
minutes) to deplete the cholesterol or with CD (Sigma-Aldrich, 10 µM, in serum free DMEM 
for 60 minutes) or with Jsp (Santa Cruz Biotechnology, 3µM, in serum free DMEM for 30 
minutes) to alter the actin cytoskeleton as previously reported [29, 41, 42] before the FRAP 
experiments.  
FRAP Microscopy 
All FRAP experiments were performed on a Nikon Eclipse TE2000U inverted 
microscope (Nikon, Melville, NY) which was equipped with an oil-immersion objective 
(100×, Apo TIRF, 1.49 numerical aperture). The microscope was housed in a home built 
0.9×0.6×0.5 m3 Plexiglas box containing a heat source to maintain a 36 ± 2 ºC at the sample 
throughout the experiment. Fluorescence was excited with a mercury lamp (X-cite 120 PC, 
EXFO Photonic Solutions Inc., Mississauga, Ontario, Canada) operating at 25% of the power 
and an excitation filter (HQ545/30x, Chroma Technology Corp., Bellows Falls, VT). The 
resulting fluorescence emission was collected through an emission filter (HQ620/60x, 
Chroma Technology Corp.). For photobleaching a region of the cell membrane, a 488-nm 
laser was directed to the sample with a dichroic mirror (Q495lp, Chroma Technology Corp.). 
The laser power and photobleaching spot diameter at the sample were 10 mW and 4.0 µm, 
respectively. A LabView program (National Instruments, Austin, TX) was developed to 
control a shutter (Thorlabs, Jessup, MD) in the laser path. The photobleaching time was 2 
msec. Fluorescence images were recorded using a PhotonMAX 512B EMCCD camera 
(Princeton Instruments, Trenton, NJ) and Winview (Photometric, Tucson, AZ) image 
acquisition software. Ten pre-photobleach and 100 post-photobleach images were collected 
with a time resolution of 410 ms per image. Dark-state formation in mRFP is expected to 
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have a negligible impact on the FRAP data collected on this timescale. Data collection was 
completed within 1 h after adding imaging medium (pH=7.2, 155 mM NaCl, 5 mM KCl, 2 
mM CaCl2, 1 mM MgCl2, 2 mM NaH2PO4, 10 mM HEPES and 10 mM Glucose) to the cells.  
FRAP analysis 
The fluorescence images collected pre-photobleach and post-photobleach were 
analyzed with ImageJ (version 1.48, National Institute of Health) software. The fluorescence 
intensity from three regions of interest (ROIs) was extracted for each image in the series of 
110 images. The ROIs were classified as the photobleached region (an area on the plasma 
membrane illuminated by the laser spot), the non-photobleached region (an area on the 
plasma membrane away from the photobleached region), and the background (an area where 
there was no cell present in the field of view). Fluorescence recovery curves were 
constructed with a three-step process: (i) the background intensity was subtracted from 
fluorescence intensities in the photobleached ROI, the resulting curves were normalized with 
the fluorescence intensities from (ii) the non-photobleached ROI and (iii) the average pre-
photobleached intensity from the subsequently photobleached region to account for the lamp 
intensity fluctuations as well as photobleaching during the image acquisition period as 
described by Phair et al. [43]. Fluorescence recovery curves were analyzed and the results 
were averaged over 24 to 53 cells for each data set. The number of cells measured was lower 
for Jsp, CD and MβCD data sets. These treatments result in a smaller average spread cell 
diameter, which reduces the number of cells that can be analyzed by FRAP compared to the 
untreated cells. Mobile fractions (MF) were calculated using following equation, 
V =   −  −  × 100 (1) 
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Where F0 is the intensity immediately after photobleaching, F
0 is the pre-photobleaching 
intensity and F∞ is the final intensity (i.e., in image 110), where all fluorescence intensities 
refer to the values from the fluorescence recovery curves. Each fluorescence recovery curve 
was further fit with below equation using IGOR Pro V 6.32A (WaveMetrics Inc., Lake 
Oswego, OR) to measure the time dependency of the fluorescence recovery as well as 
diffusion coefficients [36]. 
() =  +  


1 + 
  (2) 
Where F(t) is the fluorescence intensity at time t, α is the time exponent and τ is time for 50% 
fluorescence recovery. Diffusion coefficients were calculated using below equation.  
 = ω4 (3) 
Where D(t) is the diffusion coefficient at time t and ω is the radius of the photobleached spot. 
The statistical significance of all reported data sets was calculated using first the F-test at the 
95% confidence level and then the homoscedastic/heteroscedastic (as determined from the F-
test) Student’s t-test with a two-tailed distribution. The resulting p values that indicate 
statistical differences are reported in Figure 4.7; statistical differences at the 95% confidence 
level (i.e., p values below 0.05) are considered significant. Diffusion parameters are 
presented as box-and-whisker plots. For box-and-whisker plots, the boundary of the box 
shows the twenty-fifth and seventy-fifth quartiles. A line and a triangle within the box 
indicate the median and the mean, respectively. Whiskers above and below the boxes are 1.5 
times the interquartile range.   
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Actin cytoskeleton staining 
Cells were sub-cultured onto glass-bottom petri dishes and allowed to spread in the 
incubator for two days before the experiment. Cells were treated as described above with 5 
mM MβCD, 10 µM CD, or 3 µM Jsp before the actin cytoskeleton was stained for 
fluorescence imaging. The staining protocol was described previously [44]. Briefly, cells 
were fixed with 4% (w/v) paraformaldehyde in PBS for 10 minutes. Triton X-100 (0.1% 
(v/v) in PBS) was used for cell membrane permeabilization. Blocking was performed using 
bovine serum albumin (1% (w/v) in PBS) for 5 minutes. Cells were further incubated with 
Atto 647N conjugated phalloidin (Sigma-Aldrich) to stain the F-actin overnight at 4 °C. 
Stained cells were rinsed with imaging medium before imaging using the Nikon Eclipse 
TE2000U inverted microscope described above. The actin cytoskeleton was further 
quantified to measure the alignment in the actin fibers in 21 to 41 cells. Alignment was 
calculated using an ImageJ plugin, FibrilTool, as described previously [45].  
 
4.4 Results and Discussion 
Characterization of RAGE and RAGE-mRFP Expression 
The primary goal of this study is to probe the lateral diffusion of RAGE in the 
GM07373 cell membrane in order to characterize the role of the actin cytoskeletal and 
cholesterol in altering RAGE diffusion. To achieve this goal, plasmids were transfected into 
GM07373 cells to stably express full-length RAGE or RAGE-mRFP. RAGE or RAGE-
mRFP expression was confirmed by Western blot analysis of cell lysates as shown in Figure 
4.1. A protein band corresponding to RAGE at ~55 kDa (band 1, Figure 4.1) was observed in 
the GM07373-RAGE cell lysate (lane b, Figure 4.1) but not in the GM07373 cell lysate (lane 
a, Figure 4.1). Surprisingly, the GM07373-RAGE-mRFP cell lysate (lane c, Figure 4.1) 
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showed three bands in the 60 to 80 kDa molecular weight range after probing the membrane 
with the RAGE primary antibody. Bands 1 to 4 were positive for RAGE peptides as 
measured by mass spectrometry. After the PVDF membrane was probed with a polyclonal 
mRFP antibody, only a single band was observed from the GM07373-RAGE-mRFP cell 
lysate (band 5, Figure 4.1) near the molecular weight of band 3. It was confirmed by 
fluorescence imaging of the PVDF membrane that fluorescence was measured only at the 
location of band 5, thus RAGE-containing bands 2 and 4 do not contribute to the 
fluorescence microscopy results reported below.  
Phosphorylation of extracellular-signal-regulated kinase (p-ERK) was used as a 
marker for downstream RAGE signaling [46, 47]. There was no statistically significant 
difference in p-ERK levels in cells expressing RAGE or RAGE-mRFP (Figure 4.2), 
indicating that the mRFP tag on RAGE did not alter p-ERK signaling in GM07373 cells. 
RAGE-mRFP diffusion in the native GM07373 cell membrane  
FRAP experiments on GM07373 cells expressing RAGE-mRFP were performed and 
the average recovery curve from 24-53 cells is shown in Online Resource 1 (Figure S4.1). 
Each replicate curve was individually fit to the time-dependent diffusion model with an 
immobile fraction (i.e., all parameters α, F0, F∞ and τ in equation 2 were allowed to vary) as 
described by Federer et al. [36]. The time exponent (α) from the fit parameters provides 
information on the nature of the mode of diffusion. An α value of 1 indicates time-
independent Brownian diffusion, whereas a value less than 1 indicates time-dependent 
diffusion. The average α value measured for RAGE-mRFP was 0.9 (Figure 4.7). The average 
mobile fraction was 90% and the average diffusion coefficient was 0.3 µm2/s for RAGE-
mRFP at native cellular conditions. While FRAP provides a measure of the average diffusion 
properties of RAGE-mRFP, it is known that RAGE diffusion is heterogeneous [48]. For 
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example, when the diffusion coefficient is measured one receptor at a time across 100 
receptors, the diffusion coefficient varies by over 4 orders of magnitude. The heterogeneity 
in RAGE diffusion is not detectable with the ensemble FRAP method. On the other hand, 
FRAP measurements yield the fraction of mobile RAGE, which has not been possible to 
measure with other analysis techniques [48].   
Alterations to the F-actin cytoskeleton alter RAGE-mRFP diffusion properties 
measured by FRAP 
To study the possible effect of the actin cytoskeleton on RAGE lateral diffusion, the 
actin cytoskeleton was altered with two drugs, CD and Jsp. CD depolymerizes the 
filamentous actin cytoskeleton and prevents repolymerization by binding to actin monomers 
[49]. Jsp binds with filamentous actin and inhibits depolymerization [50].  Atto 647N 
conjugated phalloidin was used to measure the effect of CD and Jsp on the actin cytoskeleton 
in GM07373-RAGE cells as shown in Figure 4.3. In the native GM07373 cells, the actin 
cytoskeleton staining generated partially aligned fibers with a well-defined cell boundary as 
shown in Figure 4.3a. After the CD treatment, the actin structure was significantly altered 
and no clear cell boundary was observed (Figure 4.3c). Jsp binds to the actin cytoskeleton in 
competition with the Atto 647N conjugated phalloidin [51]. Hence, Atto 647N phalloidin 
actin cytoskeleton staining was diminished for Jsp treated cells (Figure 4.3d). There was no 
change in the actin expression as measured from Western blot analysis of the cell lysate 
treated with CD or Jsp (Figure 4.4). 
RAGE-mRFP diffusion parameters were measured for CD or Jsp treated cells. The 
RAGE-mRFP mobile fraction and diffusion coefficient were decreased by 22% and 37%, 
respectively, when the actin cytoskeleton was altered with Jsp (Figure 4.7). In contrast, CD 
treatment does not alter the RAGE diffusion properties. Jsp and CD have opposite effects on 
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the polymerization of the actin cytoskeleton. Jsp hinders depolymerization, whereas CD 
depolymerizes the actin filaments. Jsp results in less mobile and slower RAGE, suggesting an 
actin cytoskeleton fixed in a polymerized state slows RAGE diffusion and reduces the mobile 
fraction. Surprisingly, CD treatment to depolymerize the actin cytoskeleton does not 
statistically increase RAGE mobility as measured by FRAP; although it is noteworthy that 
prior to altering the actin cytoskeleton RAGE diffusion is already relatively unhindered with 
a large mobile fraction and nearly Brownian behavior as indicated by the  value. 
 To understand if RAGE diffusion properties are linked to downstream signaling, 
phosphorylation of ERK (p-ERK) was measured in both GM07373 and GM07373-RAGE 
cells after CD and Jsp treatment. p-ERK was decreased by 70% and 50% in GM07373-
RAGE cells when the actin cytoskeleton was disrupted with CD and JSP, respectively 
(Figure 4.5a and 4.5b). There was no statistically significant change in p-ERK observed in 
GM07373 cells lacking detectable RAGE expression after CD or Jsp treatment (Figure 4.5c 
and 4.5d). This indicates that the downstream signaling of RAGE is altered when the actin 
cytoskeleton is disrupted, regardless of the effects disrupting the actin cytoskeleton has on 
RAGE diffusion.   
To investigate the effect of cholesterol on the lateral diffusion of RAGE-mRFP, 
cholesterol was depleted using MβCD. The total free cholesterol was depleted by 45% and 
no statistically significant change in the endogenous cholesterol ester was observed when 
cells were incubated with 5 mM MβCD as measured by Amplex® Red cholesterol 
quantification assay (Figure 4.6a). The diffusion parameters statistically unchanged for 
RAGE-mRFP (Figure 4.7). There was also no change in p-ERK measured after cholesterol 
depletion from both GM07373-RAGE cells and GM07373 (Figure 4.6b and 4.6d). These 
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conclusions are valid in the absence of RAGE ligand. In the presence of ligand, RAGE 
signaling may be dependent on cholesterol as previously reported [32].  
It has been previously reported that a change in membrane cholesterol not only 
affects the cell membrane structure but also has a global effect, including reorganization of 
the actin structure [52]. This appears to be valid in GM07373-RAGE cells (Figure 4.3a and 
4.3b). A significant 40% decrease in the actin fiber alignment was measured after cholesterol 
depletion in both the GM07373-RAGE and GM07373 cell lines. No change in the actin 
expression was observed with cholesterol depletion (Figure 4.6). These observations indicate 
that cholesterol depletion affects the actin cytoskeleton organization, but the cholesterol-
depletion-induced changes to the actin cytoskeleton alignment are not associated with 
changes in RAGE diffusion properties.  
In summary, RAGE-mRFP diffuses in the cell membrane with a large mobile fraction 
at native GM07373 cellular conditions. The depolymerization of the actin cytoskeleton plays 
a role in how RAGE diffuses in the membrane, and more generally, the actin cytoskeleton 
polymerization dynamics alter the downstream signaling of RAGE. Even though there is a 
significant change in the actin cytoskeleton alignment as revealed by phalloidin staining, 
cholesterol depletion has no effect on RAGE lateral diffusion as measured by FRAP or 
signaling as measured by p-ERK. The combined data point to an important role for actin 
depolymerization in the diffusion properties of RAGE and a link between the actin 
cytoskeleton and RAGE-mediated p-ERK signaling. 
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4.6 Figures and Tables 
 
Figure 4.1. Western blot analysis of (a) GM07373 cell lysate, (b) GM07373-RAGE cell 
lysate, and (c) GM07373-RAGE-mRFP cell lysate. (Top) fluorescence image of the PVDF 
membrane probed with anti-RAGE antibody; (bottom) fluorescence image of the PVDF 
membrane probed with anti-mRFP antibody. Unlabeled bands (three upper bands in the top 
image and three lower bands in the bottom image) are present in all lanes and likely represent 
non-specific interactions of antibodies.   
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Figure 4.2. Western blot analysis of phosphorylation of ERK and total-ERK expression in 
the GM07373-RAGE cell lysate and GM07373-RAGE-mRFP cell lysate. (a) Fluorescence 
image of the PVDF membrane probed with anti-p-ERK or anti-total-ERK antibody. (b) 
Average (n = 3) fluorescence intensities of the 42 kDa band of p-ERK divided by the 42 kDa 
total-ERK band. Error bars represent one standard deviation.  
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Figure 4.3. Fluorescence images of GM07373-RAGE cells with the actin cytoskeleton 
stained with Atto 647N conjugated phalloidin. (a) No treatment, (b) 5 mM methyl-β-
cyclodextrin treatment, (c) 10 µM cytochalasin-D treatment, or (d) 3 µM Jasplakinolide 
treatment. The intensity scales are: (a) and (b) 1700 to 7000 intensity units, (c) 1500 to 3000 
intensity units, and (d) 1500 to 1700 intensity units. The scale bar is 20 µm and is the same 
for all images.   
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Figure 4.4 Western blot analysis of actin expression in the (a, b) GM07373-RAGE and (c, d) 
GM07373 cell lysate with no treatment (No), 10 µM cytochalasin D (CD) treatment, or 3 µM 
Jasplakinolide (Jsp) treatment. (a, c) Fluorescence image of the PVDF membrane probed 
with anti-actin or anti-vinculin antibody. (b, d) Average (n = 3) fluorescence intensities of the 
actin band divided by the vinculin band. Error bars represent one standard deviation. 
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Figure 4.5. Western blot analysis of phosphorylation of ERK and total-ERK expression in 
the (a, b) GM07373-RAGE and (c, d) GM07373 cell lysate with no treatment (No), 10 µM 
cytochalasin D (CD) treatment, or 3 µM Jasplakinolide (Jsp) treatment. (a, c) Fluorescence 
image of the PVDF membrane probed with anti-p-ERK or anti-total-ERK antibody. (b, d) 
Average (n = 3) fluorescence intensities of the 42 kDa band of p-ERK divided by the 42 kDa 
total-ERK band. The band intensities were normalized to the no treatment band. Error bars 
represent one standard deviation. 
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Figure 4.6. (a) Cholesterol quantification with Amplex® Red assay. Average (n = 2) free 
cholesterol (1 and 2) and cholesterol ester (3 and 4) concentration as measured from 
GM07373-RAGE cell lysate at native cellular conditions (1 and 3) and 5 mM methyl-β-
cyclodextrin (MβCD) treated (2 and 4). Effect of MβCD treatment on (b, c) GM07373-
RAGE cells and (d, e) GM07373 cells. (b, d) Fluorescence image of the PVDF membrane 
probed with anti-p-ERK, anti-total-ERK, anti-actin or anti-vinculin antibody. (c, e) Average 
(n=4) fluorescence intensities of the 42 kDa band of p-ERK divided by the 42 kDa total-ERK 
band (left); Average (n=2) fluorescence intensities of the actin band divided by the vinculin 
band (right). Error bars represent one standard deviation. 
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Figure 4.7. Box-and-whisker plots (n = 24 to 53) of RAGE-mRFP diffusion parameters in 
the GM07373 cell membrane obtained by FRAP after no treatment (No), 5 mM methyl-β-
cyclodextrin (MβCD) treatment, 10 µM cytochalasin D (CD) treatment, or 3 µM 
Jasplakinolide (Jsp) treatment. The median and mean are represented as a horizontal line and 
triangle, respectively. The box limits are 50% (25–75%), the whiskers indicates 1.5 times the 
interquartile range, and the outliers are shown as open circles. *** indicates a statistically 
different from no treatment at the p<0.001 level. 
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4.7 Supporting Information 
Plasmids and transfection 
Full-length human RAGE coding pcDNA3 vector (pcDNA3.RAGE) was a generous 
gift from Prof. Ann Marie Schmidt (New York School of Medicine, [1]. pcDNA3.mRFP 
plasmid was purchased from Addgene (#13032, Cambridge, MA). All oligonucleotides were 
obtained from Integrated DNA Technologies (Coralville, IA). To generate mRFP fused 
RAGE (pcDNA3.RAGE-mRFP), the RAGE sequence of pcDNA3.RAGE was amplified by 
polymerase chain reaction (PCR) using 5'-
CCGGAATTCATGGCAGCCGGAACAGCAGTT-3' and 5'-
CCGCTCGAGAGGCCCTCCAGTACTACTCTC-3' primers. The amplified RAGE region 
was sub-cloned into EcoRI/XhoI restriction sites of the pcDNA3.mRFP vector. The DNA 
sequence coding for human influenza hemagglutinin (HA) tag (YPYDVPDYA) was inserted 
in the N-terminal of RAGE and RAGE-mRFP plasmids using the following oligonucleotides 
5’-TACCCGTACGACGTGCCGGACTACGCCATCACAGCCCGGATTGGC-3’ and 5’-
GGCG- TAGTCCGGCACGTCGTAGTTTTGAGCACCTACTACTGCCC-3’ to generate 
pcDNA3.HA-RAGE or pcDNA3.HA-RAGE-mRFP plasmids. The recombinant plasmids 
were first transformed into DH5α E. Coli cells and transformed cells were selected on Luria 
broth agar (US biological, Salem, MA) plates containing 50 µg/mL Carbenicillin (Sigma-
Aldrich, St. Louis, MO). GM07373 cells were transfected with purified recombinant 
plasmids obtained from DH5α cells using Lipofectamine 2000 using the manufacturer's 
instructions (Life Technology). Transfected GM07373 cells were selected using Geneticine 
sulfate (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) in the complete growth medium.  
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Immunoprecipitation and LC-MS/MS analysis of RAGE and RAGE-mRFP 
RAGE and RAGE-mRFP were purified using an N-terminal HA tag. Cell lysates 
from HA-RAGE or HA-RAGE-mRFP expressing GM07373 cells were incubated overnight 
at 4 ºC with anti-HA antibody conjugated agarose beads (Thermo Scientific). Agarose beads 
were washed with phosphate buffered saline (PBS) five times to remove the non-specifically 
bound components from the crude cell lysate. Bound HA-RAGE or HA-RAGE-mRFP was 
eluted by incubating the beads at 70 ºC for 10 minutes with sodium dodecyl sulfate sample 
buffer (5% SDS, 5% Glycerol, 125 mM Tris-HCl (pH=6.8) and 0.01% Bromophenol Blue) 
with a reducing agent (5 mM Dithiothreitol). After centrifuging the beads (14,000 rpm, 3 
minutes), supernatant from the elution step was directly added to a pre-cast protein gel for 
separation by electrophoresis.  Coomassie stained protein bands corresponding to HA-RAGE 
or HA-RAGE-mRFP were excised from the gel and were digested with trypsin on an 
automated ProGest (Digilab, Marlborough, MA) protein digestion station.  Digested 
fragments were loaded onto the Q-Exactive tandem mass spectrometer (Thermo Scientific) 
for LC-MS/MS analysis. The measured peptide fragments were searched with both 
SEQUEST and Mascot to identify sequence matches. 
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Figures and tables for supporting information for Chapter 2 
 
Figure S4.1. Average (n = 24 to 53) fluorescence recovery after photobleaching curves from 
RAGE-mRFP diffusion measurements in GM07373-RAGE-mRFP cells. The data are fit to 
equation 2 as outlined in the Materials and Methods (red line). CD: cytochalasin D; MβCD: 
Methyl-β-cyclodextrin; Jsp: Jasplakinolide. 
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CHAPTER 5.    GENRAL CONCLUSIONS AND FUTURE WORK 
A major goal of the work presented in this dissertation was to study the receptor for 
advanced glycation endproducts (RAGE) diffusion and clustering using different 
fluorescence imaging techniques. The lateral diffusion and clustering properties of receptors 
play a role in how receptors interact with extracellular ligands, intracellular proteins, other 
intracellular components.  More importantly, these properties affect how receptors function.  
In Chapter 2, it was shown that Diaphanous 1 (Diaph1) affected the RAGE clusters 
and RAGE’s diffusion measured by stochastic optical reconstruction microscopy and single 
particle tracking in HEK293 cells, respectively. A reduction in the expression of Diaph1 or a 
mutation in the interaction site to RAGE reduced the size and number of RAGE clusters. 
Altering a known site of interaction between RAGE and Diaph1 led to a decreased RAGE 
diffusion in both the fast and slow populations. In contrast, reducing the expression of 
Diaph1 increased RAGE diffusion in a manner that was proposed to involve actin 
polymerization.  
In Chapter 3, the extracellular ligands of RAGE binding affinity were observed to 
affect RAGE diffusion and signal transduction via single particle tracking. The ligand 
methylglyoxal modified-bovine serum albumin (MGO-BSA) was prepared and 
characterized. MGO-BSA binding to a soluble variant of RAGE was dependent on the 
percentage of primary amine modification and the net negative surface charge. Although 
MGO-BSA ligand binding affinity affected RAGE lateral diffusion, there was no direct 
correlation between MGO-BSA ligand binding affinity and RAGE diffusion. However, the 
ligand stimulated RAGE diffusion was dependent on the level of cholesterol in cells.  
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In Chapter 4, RAGE lateral diffusion was probed in native, cholesterol depleted and 
cytoskeleton altered cellular conditions by fluorescence recovery after photobleaching 
(FRAP) in GM07373 endothelial cells. It was shown that the RAGE mobile fraction, 
diffusion coefficient and phosphorylation of extracellular signal-regulated kinase (p-ERK) 
decreased when depolymerization of the actin cytoskeleton was inhibited with the small 
molecule Jasplakinolide. However, there is no statistically significant change in diffusion 
properties of RAGE or p-ERK after cholesterol depletion.  
Future work will be required to understand the molecular mechanism of RAGE 
diffusion and clustering upon chemically-defined RAGE ligands. This chemically-defined 
ligands conjugated with appropriated fluorophores could be applied to SPT or STORM. The 
effect of other receptors on RAGE diffusion could be measured. For example, there is 
recently emerging evidence that Toll-like 4 receptors (TLR4) and RAGE exhibit receptor 
“cross talk” through binding a subset of shared ligands and also through shared signal 
transduction pathways, which involve several kinases that phosphorylate their respective 
protein substrates. The interaction between RAGE and TLR4 could be measured by 
fluorescence resonance energy transfer.  A dual-color SPT or a dual-color STORM should be 
developed for determining nanoscale organization and diffusion of RAGE and TLR4.  
